0001117480 us-gaap:OverAllotmentOptionMember 2014-05-25 2014-05-27 0001117480 2013-10-21 2013-10-23 0001117480 2013-03-23 2013-03-25 0001117480 2013-10-23 0001117480 cmrx:The2013EmployeeStockPurchasePlanMember 2013-06-30 0001117480 cmrx:The2013EmployeeStockPurchasePlanMember 2013-02-28 0001117480 cmrx:The2013PlanMember 2013-12-30 2014-01-02 0001117480 us-gaap:MaximumMember us-gaap:ResearchAndDevelopmentArrangementMember 2011-02-01 2011-02-28 0001117480 cmrx:SecondTrancheMember 2012-01-27 0001117480 2012-01-27 0001117480 cmrx:FirstTrancheMember 2012-01-27 0001117480 cmrx:LoanAndSecurityAgreementMember 2014-04-01 2014-06-30 0001117480 cmrx:LoanAndSecurityAgreementMember 2014-01-01 2014-06-30 0001117480 cmrx:LoanAndSecurityAgreementMember 2013-04-01 2013-06-30 0001117480 cmrx:LoanAndSecurityAgreementMember 2013-01-01 2013-06-30 0001117480 cmrx:The2013EmployeeStockPurchasePlanMember 2014-03-31 0001117480 cmrx:The2013EmployeeStockPurchasePlanMember 2014-01-01 2014-06-30 0001117480 us-gaap:ScenarioForecastMember 2014-01-01 2014-06-30 0001117480 cmrx:The2013EmployeeStockPurchasePlanMember 2014-04-01 2014-06-30 0001117480 cmrx:FirstTrancheMember 2012-03-31 0001117480 us-gaap:WarrantMember 2013-04-08 2013-04-10 0001117480 us-gaap:SeriesFPreferredStockMember 2013-04-08 2013-04-10 0001117480 us-gaap:ResearchAndDevelopmentArrangementMember 2014-01-01 2014-06-30 0001117480 us-gaap:MaximumMember us-gaap:ScenarioPlanMember us-gaap:ResearchAndDevelopmentArrangementMember 2011-02-01 2011-02-28 0001117480 cmrx:The2013PlanMember 2014-06-30 0001117480 2013-03-31 0001117480 2013-06-30 0001117480 2012-12-31 0001117480 us-gaap:CertificatesOfDepositMember 2014-01-01 2014-06-30 0001117480 us-gaap:CorporateNoteSecuritiesMember 2014-01-01 2014-06-30 0001117480 us-gaap:CommercialPaperMember 2014-01-01 2014-06-30 0001117480 us-gaap:CorporateNoteSecuritiesMember 2014-06-30 0001117480 us-gaap:CommercialPaperMember 2014-06-30 0001117480 us-gaap:CertificatesOfDepositMember 2014-06-30 0001117480 us-gaap:ShortTermInvestmentsMember us-gaap:FairValueInputsLevel2Member 2014-06-30 0001117480 us-gaap:CashAndCashEquivalentsMember us-gaap:FairValueInputsLevel1Member 2014-06-30 0001117480 us-gaap:ShortTermInvestmentsMember 2014-06-30 0001117480 us-gaap:CashAndCashEquivalentsMember 2014-06-30 0001117480 us-gaap:CashAndCashEquivalentsMember us-gaap:FairValueInputsLevel1Member 2013-12-31 0001117480 us-gaap:CashAndCashEquivalentsMember 2013-12-31 0001117480 us-gaap:ShortTermInvestmentsMember us-gaap:FairValueInputsLevel3Member 2013-06-30 0001117480 us-gaap:CashAndCashEquivalentsMember us-gaap:FairValueInputsLevel3Member 2013-06-30 0001117480 us-gaap:CommonStockMember 2014-01-01 2014-06-30 0001117480 2014-08-01 0001117480 cmrx:BrincidofovirMember us-gaap:MaximumMember 2014-01-01 2014-06-30 0001117480 2014-05-25 2014-05-27 0001117480 us-gaap:OverAllotmentOptionMember 2013-04-14 2013-04-16 0001117480 2013-04-08 2013-04-10 0001117480 cmrx:The2013PlanMember 2014-06-18 2014-06-20 0001117480 cmrx:The2013PlanMember 2014-01-01 2014-03-31 0001117480 cmrx:The2013EmployeeStockPurchasePlanMember 2013-02-01 2013-02-28 0001117480 cmrx:RegentsOfUniversityOfCaliforniaMember 2002-05-01 2002-05-31 0001117480 2014-06-30 0001117480 2013-12-31 0001117480 us-gaap:ResearchAndDevelopmentArrangementMember 2011-02-01 2011-02-28 0001117480 cmrx:SecondTrancheMember 2012-01-01 2012-03-31 0001117480 cmrx:FirstTrancheMember 2012-01-01 2012-03-31 0001117480 us-gaap:ResearchAndDevelopmentExpenseMember cmrx:EmployeeMember 2014-04-01 2014-06-30 0001117480 us-gaap:GeneralAndAdministrativeExpenseMember cmrx:EmployeeMember 2014-04-01 2014-06-30 0001117480 2014-04-01 2014-06-30 0001117480 us-gaap:ResearchAndDevelopmentExpenseMember cmrx:EmployeeMember 2014-01-01 2014-06-30 0001117480 us-gaap:GeneralAndAdministrativeExpenseMember cmrx:EmployeeMember 2014-01-01 2014-06-30 0001117480 us-gaap:ResearchAndDevelopmentExpenseMember cmrx:NonEmployeeMember 2013-04-01 2013-06-30 0001117480 us-gaap:ResearchAndDevelopmentExpenseMember cmrx:EmployeeMember 2013-04-01 2013-06-30 0001117480 us-gaap:GeneralAndAdministrativeExpenseMember cmrx:NonEmployeeMember 2013-04-01 2013-06-30 0001117480 us-gaap:GeneralAndAdministrativeExpenseMember cmrx:EmployeeMember 2013-04-01 2013-06-30 0001117480 us-gaap:ResearchAndDevelopmentExpenseMember cmrx:NonEmployeeMember 2013-01-01 2013-06-30 0001117480 us-gaap:ResearchAndDevelopmentExpenseMember cmrx:EmployeeMember 2013-01-01 2013-06-30 0001117480 us-gaap:GeneralAndAdministrativeExpenseMember cmrx:NonEmployeeMember 2013-01-01 2013-06-30 0001117480 us-gaap:GeneralAndAdministrativeExpenseMember cmrx:EmployeeMember 2013-01-01 2013-06-30 0001117480 2013-04-01 2013-06-30 0001117480 2013-01-01 2013-06-30 0001117480 cmrx:The2013EmployeeStockPurchasePlanMember 2014-06-30 0001117480 cmrx:The2013EmployeeStockPurchasePlanMember 2013-12-30 2014-01-02 0001117480 2014-01-01 2014-06-30 0001117480 us-gaap:CommonStockMember 2014-06-30 0001117480 cmrx:FormerChiefExecutiveOfficerMember 2014-04-01 2014-06-30 iso4217:USD xbrli:shares xbrli:pure cmrx:item iso4217:USD xbrli:shares P15M 1330958 <div> <div style="margin-left:0pt;margin-right:0pt;"> Clinical Trial Accruals/Prepaids As part of the process of preparing financial statements, the Company is required to estimate its expenses resulting from its obligation under contracts with vendors and consultants and clinical site agreements in connection with conducting clinical trials. The financial terms of these contracts are subject to negotiations which vary contract to contract and may result in payment flows that do not match the periods over which materials or services are provided to the Company under such contracts. The Company’s objective is to reflect the appropriate clinical trial expenses in its financial statements by matching those expenses with the period in which services and efforts are expended. The Company accounts for these expenses according to the progress of the trial as measured by patient progression and the timing of various aspects of the trial. Depending on amounts paid to the contract research organization and other third-party vendors as compared to actual expenses incurred, there might be a prepaid balance recorded as a prepaid asset. The Company determines accrual estimates through discussion with applicable personnel and outside service providers as to the progress or state of completion of trials, or the services completed. During the course of a clinical trial, the Company adjusts its rate of clinical trial expense recognition if actual results differ from its estimates. The Company makes estimates of its accrued expenses as of each balance sheet date in its financial statements based on facts and circumstances known at that time. Although the Company does not expect its estimates to be materially different from amounts actually incurred, its understanding of status and timing of services performed relative to the actual status and timing of services performed may vary and may result in the Company reporting amounts that are too high or too low for any particular period. Through June 30, 2014, there had been no material adjustments to the Company’s prior period estimates of accrued expenses for clinical trials. The Company’s clinical trial accrual is dependent upon the timely and accurate reporting of contract research organizations and other third-party vendors. </div> </div> 266649 956690 <div> <div style="margin-left:0pt;margin-right:0pt;"> 5.  Equity Transactions and Share-based Compensation   Warrants  Upon the completion of the Company’s IPO, all outstanding warrants to purchase redeemable convertible preferred stock were marked to market resulting in a $4.3 million fair value adjustment for the three months ended June 30, 2013 and a  $6.4 million fair value adjustment for the six months ended June 30, 2013. The warrants were then converted into warrants to purchase 1,613,395 shares of common stock and were no longer required to be measured at fair value.   The following warrants for the purchase of common stock were issued, outstanding and exercisable at June 30, 2014:   <div style="width:100%"><table cellpadding="0" cellspacing="0" style="border-collapse:collapse;width: 100.00%;margin-left:0pt;"> <tr> <td valign="bottom" style="width:31.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:01.16%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:17.76%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:01.16%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:01.16%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:11.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:01.16%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:01.16%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:01.16%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:11.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:01.16%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:01.16%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:17.76%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> </tr> <tr> <td valign="bottom" style="width:31.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> Class </td> <td valign="bottom" style="width:01.16%;padding:0pt;">   </td> <td valign="bottom" style="width:17.76%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> Date </td> <td valign="bottom" style="width:01.16%;padding:0pt;">   </td> <td colspan="2" valign="bottom" style="width:13.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> Shares </td> <td valign="bottom" style="width:01.16%;padding:0pt;">   </td> <td valign="bottom" style="width:01.16%;padding:0pt;">   </td> <td colspan="2" valign="bottom" style="width:13.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> Price Per Share </td> <td valign="bottom" style="width:01.16%;padding:0pt;">   </td> <td valign="bottom" style="width:01.16%;padding:0pt;">   </td> <td valign="bottom" style="width:17.76%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> Expiration </td> </tr> <tr> <td valign="bottom" style="width:31.44%;padding:0pt;"> Common </td> <td valign="bottom" style="width:01.16%;padding:0pt;">   </td> <td valign="bottom" style="width:17.76%;padding:0pt;"> February 7, 2011 </td> <td valign="bottom" style="width:01.16%;padding:0pt;">   </td> <td valign="bottom" style="width:01.16%;padding:0pt;">   </td> <td valign="bottom" style="width:11.90%;;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>1,330,958  </td> <td valign="bottom" style="width:01.16%;padding:0pt;">   </td> <td valign="bottom" style="width:01.16%;padding:0pt;">   </td> <td valign="bottom" style="width:01.16%;padding:0pt;"> $ </td> <td valign="bottom" style="width:11.90%;;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>7.26  </td> <td valign="bottom" style="width:01.16%;padding:0pt;">   </td> <td valign="bottom" style="width:01.16%;padding:0pt;">   </td> <td valign="bottom" style="width:17.76%;padding:0pt;"> February 2018 </td> </tr> </table></div>     Stock Options  In connection with the Company’s IPO, the Company adopted the 2013 Equity Incentive Plan (the 2013 Plan).  The 2013 Plan provides for the grant of incentive stock options (ISOs), nonstatutory stock options (NSOs), stock appreciation rights, restricted stock awards, restricted stock unit (RSU) awards, performance-based stock awards, and other forms of equity compensation (collectively, stock awards), all of which may be granted to employees, including officers, non-employee directors and consultants of the Company and its affiliates.  Additionally, the 2013 Plan provides for the grant of performance cash awards. On January 1, 2014, the common stock reserved for issuance under the 2013 Plan was automatically increased by 666,624 shares.  As of June 30, 2014, there was a total of 1,433,054 shares reserved for future issuance under the 2013 Plan. At the Company’s annual meeting, held on June 20, 2014, shareholders approved a change to the annual automatic increase in the number of common shares to be reserved for issuance under the 2013 Plan by changing the percentage increase from 2.5% to 4.0% of the total number of shares of capital stock outstanding on December 31 of the preceding calendar year, or a lesser number of shares determined by the Company’s board of directors.   In February 2013, the Company’s board of directors adopted the 2013 Employee Stock Purchase Plan (ESPP), which was subsequently ratified by stockholders and became effective in April 2013. The ESPP authorizes the issuance of 704,225 shares of common stock pursuant to purchase rights granted to the Company’s employees or to employees of any of its designated affiliates. The number of shares of common stock reserved for issuance will automatically increase on January 1 of each calendar year, from January 1, 2014 through January 1, 2023 by the lesser of (a) 1% of the total number of shares of common stock outstanding on December 31 of the preceding calendar year, (b) 422,535 shares, or (c) a number determined by the Company’s board of directors that is less than (a) and (b). On January 1, 2014, the common stock reserved for issuance under the ESPP was automatically increased by 266,649 shares.    For awards with only service conditions and graded-vesting features, the Company recognizes compensation expense on a straight-line basis over the requisite service period. Compensation expense recognized related to stock options, RSUs and the ESPP is as follows:   <div style="width:100%"><table cellpadding="0" cellspacing="0" style="border-collapse:collapse;margin-left:0pt;"> <tr> <td valign="bottom" style="width:37.14%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="top" style="width:00.78%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td colspan="6" valign="top" style="width:28.68%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> Three Months Ended June 30, </td> <td valign="bottom" style="width:00.94%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt 0pt 1.2pt 0pt;">   </td> <td colspan="6" valign="bottom" style="width:31.94%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> Six Months Ended June 30, </td> <td valign="bottom" style="width:00.52%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt 0pt 1.2pt 0pt;">   </td> </tr> <tr> <td valign="bottom" style="width:37.14%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="top" style="width:00.78%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td colspan="2" valign="top" style="width:14.38%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> 2014 </td> <td valign="top" style="width:00.76%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="top" style="width:00.78%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td colspan="2" valign="top" style="width:12.78%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> 2013 </td> <td valign="bottom" style="width:00.94%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt 0pt 1.2pt 0pt;">   </td> <td colspan="2" valign="bottom" style="width:15.02%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> 2014 </td> <td valign="bottom" style="width:00.94%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt 0pt 1.2pt 0pt;">   </td> <td valign="bottom" style="width:00.94%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt 0pt 1.2pt 0pt;">   </td> <td colspan="2" valign="bottom" style="width:15.06%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> 2013 </td> <td valign="bottom" style="width:00.52%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt 0pt 1.2pt 0pt;">   </td> </tr> <tr> <td valign="bottom" style="width:37.14%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="top" style="width:00.78%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td colspan="6" valign="top" style="width:28.68%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> (in thousands) </td> <td valign="bottom" style="width:00.94%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td colspan="6" valign="bottom" style="width:31.94%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> (in thousands) </td> <td valign="bottom" style="width:00.52%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> </tr> <tr> <td valign="bottom" style="width:37.14%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFCC;padding:0pt 0pt 0pt 12pt;"> Research and development: </td> <td valign="top" style="width:00.78%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFCC;padding:0pt;">   </td> <td valign="top" style="width:00.96%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFCC;padding:0pt;">   </td> <td valign="top" style="width:13.42%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFCC;padding:0pt;">   </td> <td valign="top" style="width:00.76%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFCC;padding:0pt;">   </td> <td valign="top" style="width:00.78%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFCC;padding:0pt;">   </td> <td valign="top" style="width:00.96%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFCC;padding:0pt;">   </td> <td valign="top" style="width:11.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFCC;padding:0pt;">   </td> <td valign="bottom" style="width:00.94%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFCC;padding:0pt;">   </td> <td valign="bottom" style="width:00.96%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFCC;padding:0pt;">   </td> <td valign="bottom" style="width:14.04%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFCC;padding:0pt;">   </td> <td valign="bottom" style="width:00.94%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFCC;padding:0pt;">   </td> <td valign="bottom" style="width:00.94%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFCC;padding:0pt;">   </td> <td valign="bottom" style="width:00.96%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFCC;padding:0pt;">   </td> <td valign="bottom" style="width:14.10%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFCC;padding:0pt;">   </td> <td valign="bottom" style="width:00.52%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFCC;padding:0pt;">   </td> </tr> <tr> <td valign="bottom" style="width:37.14%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #FFFFFF;padding:0pt 0pt 0pt 24pt;"> Employee </td> <td valign="top" style="width:00.78%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #FFFFFF;padding:0pt;">   </td> <td valign="top" style="width:00.96%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #FFFFFF;padding:0pt;"> $ </td> <td valign="top" style="width:13.42%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #FFFFFF;;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>(471 </td> <td valign="top" style="width:00.76%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #FFFFFF;"> ) </td> <td valign="top" style="width:00.78%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #FFFFFF;padding:0pt;">   </td> <td valign="top" style="width:00.96%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #FFFFFF;padding:0pt;"> $ </td> <td valign="top" style="width:11.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #FFFFFF;;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>1,574 </td> <td valign="bottom" style="width:00.94%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #FFFFFF;padding:0pt;">   </td> <td valign="bottom" style="width:00.96%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #FFFFFF;padding:0pt;"> $ </td> <td valign="bottom" style="width:14.04%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #FFFFFF;;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>(96 </td> <td valign="bottom" style="width:00.94%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #FFFFFF;"> )  </td> <td valign="bottom" style="width:00.94%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #FFFFFF;padding:0pt;">   </td> <td valign="bottom" style="width:00.96%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #FFFFFF;padding:0pt;"> $ </td> <td valign="bottom" style="width:14.10%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #FFFFFF;;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>1,681 </td> <td valign="bottom" style="width:00.52%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #FFFFFF;padding:0pt;">   </td> </tr> <tr> <td valign="bottom" style="width:37.14%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFCC;padding:0pt 0pt 0pt 24pt;"> Non-employee </td> <td valign="top" style="width:00.78%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFCC;padding:0pt;">   </td> <td valign="top" style="width:00.96%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFCC;padding:0pt;">   </td> <td valign="top" style="width:13.42%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFCC;padding:0pt;"> — </td> <td valign="top" style="width:00.76%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFCC;padding:0pt;">   </td> <td valign="top" style="width:00.78%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFCC;padding:0pt;">   </td> <td valign="top" style="width:00.96%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFCC;padding:0pt;">   </td> <td valign="top" style="width:11.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFCC;;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>5 </td> <td valign="bottom" style="width:00.94%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFCC;padding:0pt;">   </td> <td valign="bottom" style="width:00.96%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFCC;padding:0pt;">   </td> <td valign="bottom" style="width:14.04%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFCC;padding:0pt;"> — </td> <td valign="bottom" style="width:00.94%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFCC;padding:0pt;">   </td> <td valign="bottom" style="width:00.94%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFCC;padding:0pt;">   </td> <td valign="bottom" style="width:00.96%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFCC;padding:0pt;">   </td> <td valign="bottom" style="width:14.10%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFCC;;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>21 </td> <td valign="bottom" style="width:00.52%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFCC;padding:0pt;">   </td> </tr> <tr> <td valign="bottom" style="width:37.14%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #FFFFFF;padding:0pt 0pt 0pt 12pt;"> General and administrative: </td> <td valign="top" style="width:00.78%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #FFFFFF;padding:0pt;">   </td> <td valign="top" style="width:00.96%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #FFFFFF;padding:0pt;">   </td> <td valign="top" style="width:13.42%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #FFFFFF;padding:0pt;">   </td> <td valign="top" style="width:00.76%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #FFFFFF;padding:0pt;">   </td> <td valign="top" style="width:00.78%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #FFFFFF;padding:0pt;">   </td> <td valign="top" style="width:00.96%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #FFFFFF;padding:0pt;">   </td> <td valign="top" style="width:11.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #FFFFFF;padding:0pt;">   </td> <td valign="bottom" style="width:00.94%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #FFFFFF;padding:0pt;">   </td> <td valign="bottom" style="width:00.96%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #FFFFFF;padding:0pt;">   </td> <td valign="bottom" style="width:14.04%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #FFFFFF;padding:0pt;">   </td> <td valign="bottom" style="width:00.94%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #FFFFFF;padding:0pt;">   </td> <td valign="bottom" style="width:00.94%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #FFFFFF;padding:0pt;">   </td> <td valign="bottom" style="width:00.96%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #FFFFFF;padding:0pt;">   </td> <td valign="bottom" style="width:14.10%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #FFFFFF;padding:0pt;">   </td> <td valign="bottom" style="width:00.52%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #FFFFFF;padding:0pt;">   </td> </tr> <tr> <td valign="bottom" style="width:37.14%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFCC;padding:0pt 0pt 0pt 24pt;"> Employee </td> <td valign="top" style="width:00.78%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFCC;padding:0pt;">   </td> <td valign="top" style="width:00.96%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFCC;padding:0pt;">   </td> <td valign="top" style="width:13.42%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFCC;;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>1,115 </td> <td valign="top" style="width:00.76%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFCC;padding:0pt;">   </td> <td valign="top" style="width:00.78%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFCC;padding:0pt;">   </td> <td valign="top" style="width:00.96%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFCC;padding:0pt;">   </td> <td valign="top" style="width:11.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFCC;;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>699 </td> <td valign="bottom" style="width:00.94%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFCC;padding:0pt;">   </td> <td valign="bottom" style="width:00.96%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFCC;padding:0pt;">   </td> <td valign="bottom" style="width:14.04%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFCC;;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>1,511 </td> <td valign="bottom" style="width:00.94%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFCC;padding:0pt;">   </td> <td valign="bottom" style="width:00.94%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFCC;padding:0pt;">   </td> <td valign="bottom" style="width:00.96%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFCC;padding:0pt;">   </td> <td valign="bottom" style="width:14.10%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFCC;;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>809 </td> <td valign="bottom" style="width:00.52%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFCC;padding:0pt;">   </td> </tr> <tr> <td valign="bottom" style="width:37.14%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #FFFFFF;padding:0pt 0pt 1.2pt 24pt;"> Non-employee </td> <td valign="top" style="width:00.78%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #FFFFFF;padding:0pt;">   </td> <td valign="top" style="width:00.96%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #FFFFFF;padding:0pt;">   </td> <td valign="top" style="width:13.42%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #FFFFFF;padding:0pt;"> — </td> <td valign="top" style="width:00.76%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #FFFFFF;padding:0pt;">   </td> <td valign="top" style="width:00.78%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #FFFFFF;padding:0pt;">   </td> <td valign="top" style="width:00.96%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #FFFFFF;padding:0pt;">   </td> <td valign="top" style="width:11.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #FFFFFF;;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>45 </td> <td valign="bottom" style="width:00.94%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #FFFFFF;padding:0pt 0pt 1.2pt 0pt;">   </td> <td valign="bottom" style="width:00.96%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #FFFFFF;padding:0pt;">   </td> <td valign="bottom" style="width:14.04%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #FFFFFF;padding:0pt;"> — </td> <td valign="bottom" style="width:00.94%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #FFFFFF;padding:0pt 0pt 1.2pt 0pt;">   </td> <td valign="bottom" style="width:00.94%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #FFFFFF;padding:0pt 0pt 1.2pt 0pt;">   </td> <td valign="bottom" style="width:00.96%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #FFFFFF;padding:0pt;">   </td> <td valign="bottom" style="width:14.10%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #FFFFFF;;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>77 </td> <td valign="bottom" style="width:00.52%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #FFFFFF;padding:0pt 0pt 1.2pt 0pt;">   </td> </tr> <tr> <td valign="bottom" style="width:37.14%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFCC;padding:0pt 0pt 3pt 12pt;">   </td> <td valign="top" style="width:00.78%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFCC;padding:0pt;">   </td> <td valign="top" style="width:00.96%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFCC;padding:0pt;"> $ </td> <td valign="top" style="width:13.42%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFCC;;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>644 </td> <td valign="top" style="width:00.76%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFCC;padding:0pt;">   </td> <td valign="top" style="width:00.78%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFCC;padding:0pt;">   </td> <td valign="top" style="width:00.96%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFCC;padding:0pt;"> $ </td> <td valign="top" style="width:11.80%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFCC;;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>2,323 </td> <td valign="bottom" style="width:00.94%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFCC;padding:0pt 0pt 3pt 0pt;">   </td> <td valign="bottom" style="width:00.96%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFCC;padding:0pt;"> $ </td> <td valign="bottom" style="width:14.04%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFCC;;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>1,415 </td> <td valign="bottom" style="width:00.94%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFCC;padding:0pt 0pt 3pt 0pt;">   </td> <td valign="bottom" style="width:00.94%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFCC;padding:0pt 0pt 3pt 0pt;">   </td> <td valign="bottom" style="width:00.96%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFCC;padding:0pt;"> $ </td> <td valign="bottom" style="width:14.10%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFCC;;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>2,588 </td> <td valign="bottom" style="width:00.52%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFCC;padding:0pt 0pt 3pt 0pt;">   </td> </tr> </table></div>    During the three months ended June 30, 2014, the Company recorded an immaterial out of period adjustment of $1.4 million to properly state additional paid-in-capital with a resulting decrease in compensation expense related to restricted stock awards that vested in 2013 in connection with the IPO. On April 9, 2014, Kenneth I. Moch, the Company’s then President and Chief Executive Officer, resigned. The Company entered into a severance agreement with Mr. Moch that provides for severance benefits to him in connection with his resignation. Among other benefits, Mr. Moch received accelerated vesting of all of his outstanding stock options as if he had continued service for an additional 15 month period.  In addition, Mr. Moch’s vested options were modified to extend the exercise period to December 31, 2014. The Company recorded a charge of $1.0 million to compensation expense on the date of his resignation related to the acceleration of vesting and the modification.   <a name="FIS_UNIDENTIFIED_TABLE_13"></a>Employee Stock Purchase Plan The Company has reserved a total of 970,874 shares of common stock to be purchased under the ESPP, of which 956,690 shares remain available for purchase at June 30, 2014. Eligible employees may authorize up to 15% of their salary to purchase common stock at the lower of 85% of the beginning price or 85% of the ending price during each six-month purchase interval. During the three months ended June 30, 2014, the Company did not issue any shares pursuant to the ESPP; for the six months ended June 30, 2014, the Company issued 14,184 shares of common stock pursuant to the ESPP. Compensation expense for shares purchased under the ESPP related to the purchase discount and the “look-back” option were determined using a Black-Scholes option pricing model. The Company recorded compensation expense of $47,000 for the three months ended June 30, 2014 and $149,000 for the six months ended June 30, 2014. There was no compensation expense recorded for the three or six months ended June 30, 2013 since the ESPP was not active during that period.     </div> </div> 6590000 4388000 2588000 809000 77000 1681000 21000 2323000 699000 45000 1574000 5000 1415000 1511000 -96000 644000 1115000 -471000 -1400000 P12M P6M P1Y P1Y P15M 4294000 1480000 3400000 4 0.01 0.025 0.04 P30M P32M 14.00 14.00 14.22 7100000 1100000 0.50 <div> <div style="margin-left:0pt;margin-right:0pt;"> 7. Significant Agreements   The Regents of the University of California In May 2002, the Company entered into a license agreement with The Regents of the University of California (UC) under which the Company obtained an exclusive, worldwide license to UC’s patent rights in certain inventions (the UC Patent Rights) related to lipid-conjugated antiviral compounds and their use, including certain patents relating to brincidofovir.  The license agreement was amended in September 2002 in order to expand the scope of the license and again in December 2010 in order to modify certain financial terms.  The agreement was amended a third time in September 2011 to add additional patents related to certain metabolically stable lipid-conjugate compounds.  A fourth amendment was executed in July 2012 to alter the rights and obligations of the parties in light of the Company’s current business plans.  As partial consideration for the rights granted to the Company under the license agreement, the Company is required to pay certain cash milestone payments in connection with the development and commercialization of compounds that are covered by the UC Patent Rights.  In connection with the development and commercialization of brincidofovir, the Company could be required to pay UC up to an aggregate of $3.4 million in milestone payments, assuming the achievement of all applicable milestone events under the license agreement.    Under the license agreement, the Company is permitted to research, develop, manufacture and commercialize products utilizing the UC Patent Rights for all human and veterinary uses, and to sublicense such rights.  UC retained the right, on behalf of itself and other non-profit institutions, to use the UC Patent Rights for educational and research purposes and to publish information about the UC Patent Rights.   In consideration for the rights granted under the license agreement, the Company has issued UC an aggregate of 64,788 shares of common stock.  As additional consideration, the Company is required to pay certain cash milestone payments in connection with the development and commercialization of compounds that are covered by the UC Patent Rights, plus certain annual fees to maintain such patents until the Company commercializes a product utilizing UC Patent Rights.  In addition, upon commercialization of any product utilizing the UC Patent Rights (which would include the commercialization of brincidofovir), the Company will be required to pay low single digit royalties on net sales of such product.   In the event the Company sublicenses a UC Patent Right (including UC Patent Rights relating to brincidofovir) the Company is obligated to pay to UC a fee, which amount will vary depending upon the size of any upfront payment the Company receives and the clinical development stage of the compound being sublicensed, but which could be up to approximately 50% of the sublicense fee in certain circumstances.  With respect to brincidofovir, the fee payable to UC will not exceed 5% of the sublicense fee.  In addition, the Company will also be required to pay to UC a low single digit sublicense royalty on net sales of products that use the sublicensed UC Patent Rights, but in no event will the Company be required to pay more than 50% of the royalties it receives in connection with the relevant sublicense.  Any such royalty payment will be reduced by other payments the Company is required to make to third parties until a minimum royalty has been reached.   The Company did not recognize expenses under this agreement for the three or six months ended June 30, 2014 or the year ended December 31, 2013.   Biomedical Advanced Research and Development Authority (BARDA) In February 2011, the Company entered into a contract with BARDA for the development of brincidofovir as a medical countermeasure in the event of a smallpox release. The contract has been amended several times, most recently on April 10, 2014, to extend the first option segment until August 31, 2014.   Under the contract, BARDA will reimburse the Company, plus pay a fixed fee, for the research and development of brincidofovir as a treatment of smallpox infections.  The contract consists of an initial performance period, referred to as the base performance segment, plus up to four extension periods of approximately one year each, referred to as option segments, each of which may be exercised at BARDA’s sole discretion.  The Company must complete the agreed upon milestones and deliverables in each discrete work segment before the next option segment is eligible to be exercised.  Under the contract as currently in effect, the Company may receive up to $75.8 million in expense reimbursement and $5.3 million in fees if all remaining option segments are exercised.   The Company is currently performing under the first option segment of the contract during which the Company may receive up to a total of $5.3 million in expense reimbursement and fees.  In April 2014, the Company and BARDA extended the term of the first option segment to a period of 15 months, currently scheduled to end on August 31, 2014. For the three and six months ended June 30, 2014, the Company recognized revenue of $0.9 million and $1.7 million, respectively, under this contract.      </div> </div> 0.05 0.50 1613395 false --12-31 Q2 2014 2014-06-30 10-Q 0001117480 35669451 Non-accelerated Filer CHIMERIX INC 2018-02-01

2214000

3055000

248000

288000

-149000

-385000

2420000

3553000

-20000

261243000

375504000

1000000

224000

83000

7808128

4244971

3189265

3187867

113387000

204658000

113009000

204151000

107349000

118228000

80996000

118228000

80996000

81016000

4800000

26224000

49992000

80996000

4796000

26225000

49975000

1000

-20000

12000

6000

5000

1000

26000

4000

18000

<div> <div style="margin-left:0pt;margin-right:0pt;"> 1. The Business and Summary of Significant Accounting Policies   Description of Business Chimerix, Inc. (the Company) is a biopharmaceutical company dedicated to discovering, developing and commercializing novel, oral antivirals to address unmet medical needs. The Company was founded in 2000 based on the promise of its proprietary lipid technology to unlock the potential of some of the most potent antivirals by enhancing their antiviral activity and safety profiles in convenient, orally administered dosing regimens. Based on the Company’s proprietary lipid technology, its lead compound, brincidofovir (BCV, CMX001), is in Phase 3 clinical development; in addition, the Company has an active discovery program focusing on viral targets for which no therapies are currently available.   On March 25, 2013, the Company’s board of directors approved and implemented a 3.55-for-1 reverse split of the Company’s outstanding common stock. The accompanying financial statements and notes to the financial statements give retroactive effect to the reverse stock split for all periods presented. <p style="margin:0pt 18pt 0pt 0pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;border-top:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;font-family:Times New Roman;font-size: 10pt">   On April 10, 2013, the Company completed the initial public offering (IPO) of its common stock pursuant to a registration statement on Form S-1. In the IPO, the Company sold an aggregate of 7,320,000 shares of common stock under the registration statement at a public offering price of $14.00 per share. Net proceeds were approximately $93.3 million, after deducting underwriting discounts and commissions of $7.1 million and offering expenses of $2.1 million. Upon the completion of the IPO, all outstanding shares of the Company’s redeemable convertible preferred stock and dividends accrued on Series F redeemable convertible preferred stock were converted into 15,556,091 shares of common stock and all outstanding warrants to purchase redeemable convertible preferred stock were converted into warrants to purchase 1,613,395 shares of common stock.  On April 16, 2013, the underwriters exercised the full over-allotment option pursuant to which the Company sold an additional 1,098,000 shares of common stock at $14.00 per share. Net proceeds from the over-allotment shares were approximately $14.3 million after deducting underwriting discounts and commissions of $1.1 million.   On October 23, 2013, the Company completed an underwritten secondary public offering of 2,476,995 shares of common stock held by certain of the Company’s existing stockholders at a price to the public of $16.50 per share. The Company did not issue any shares of common stock and received no proceeds in connection with such offering. The principal purposes of the offering were to facilitate an orderly distribution of shares and to increase the Company’s public float.   On May 27, 2014, the Company completed an underwritten public offering of 8,395,000 shares of common stock, including 1,095,000 shares sold pursuant to the full exercise of an over-allotment option previously granted to the underwriters. All of the shares were offered by the Company at a price to the public of $14.22 per share. Net proceeds to the Company from this offering, after deducting underwriting discounts and commissions and other offering expenses payable by the Company, were approximately $111.8 million. The securities described above were offered by the Company pursuant to a shelf registration statement declared effective by the Securities and Exchange Commission (the SEC) on May 16, 2014.   The accompanying unaudited financial statements have been prepared in accordance with U.S. generally accepted accounting principles, or GAAP, for interim financial information, the instructions to Form 10-Q and Article 10 of Regulation S-X. Accordingly, they do not include all of the information and footnotes required by GAAP for complete financial statements and should be read in conjunction with the Company’s audited financial statements and notes thereto included in its Annual Report on Form 10-K for the year ended December 31, 2013.  In the opinion of the Company’s management, all adjustments, consisting of normal recurring adjustments, necessary for a fair presentation of its financial position, operating results and cash flows for the periods presented have been included.  Operating results for the three and six months ended June 30, 2014 are not necessarily indicative of the results that may be expected for the full year, for any other interim period or for any future year.    Use of Estimates The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the amounts of assets, liabilities, revenues and expenses reported in the financial statements and accompanying notes.  Actual results could differ from these estimates.    Fair Value of Financial Instruments The carrying amounts of certain financial instruments, including accounts receivable, accounts payable and accrued expenses approximate their fair values due to the short-term nature of such instruments.  The carrying amount of borrowings under loans payable approximates its fair value based on the determination that the stated rate on such loans payable is consistent with current interest rates for similar borrowing arrangements available to the Company. <p style="margin:0pt 20.9pt 0pt 0pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;border-top:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;font-family:Times New Roman;font-size: 10pt">   For assets and liabilities recorded at fair value, it is the Company’s policy to maximize the use of observable inputs and minimize the use of unobservable inputs when developing fair value measurements, in accordance with the fair value hierarchy.  Fair value measurements for assets and liabilities where there exists limited or no observable market data are based primarily upon estimates and are often calculated based on the economic and competitive environment, the characteristics of the asset or liability and other factors.  Therefore, fair value measurements cannot be determined with precision and may not be realized in an actual sale or immediate settlement of the asset or liability.  Additionally, there may be inherent weaknesses in any calculation technique and changes in the underlying assumptions used, including discount rates and estimates of future cash flows, could significantly affect the calculated current or future fair values.  The Company utilizes fair value measurements to record fair value adjustments to certain assets and liabilities and to determine fair value disclosures. <p style="margin:0pt 20.9pt 0pt 0pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;border-top:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;font-family:Times New Roman;font-size: 10pt">   The Company groups assets and liabilities at fair value in three levels, based on the markets in which the assets and liabilities are traded and the reliability of the assumptions used to determine fair value.  An adjustment to the pricing method used within either Level 1 or Level 2 inputs could generate a fair value measurement that effectively falls in a lower level in the hierarchy.  These levels are:   <div style="width:100%"><table cellpadding="0" cellspacing="0" style="border-collapse:collapse;width: 100.00%;CellSpacing:0;margin-left:0pt;"> <tr style="CellSpacing:0;"> <td valign="top" style="width:18.00pt;padding:0pt;">   </td> <td valign="top" style="width:18.00pt;padding:0pt;">   </td> <td valign="top" style="width:auto;padding:0pt 21.6pt 0pt 0pt;"> Level 1 — Valuations based on unadjusted quoted prices in active markets for identical assets or liabilities that the Company has the ability to access. </td> </tr> </table></div>   <div style="width:100%"><table cellpadding="0" cellspacing="0" style="border-collapse:collapse;width: 100.00%;CellSpacing:0;margin-left:0pt;"> <tr style="CellSpacing:0;"> <td valign="top" style="width:18.00pt;padding:0pt;">   </td> <td valign="top" style="width:18.00pt;padding:0pt;">   </td> <td valign="top" style="width:auto;padding:0pt 21.6pt 0pt 0pt;"> Level 2 — Valuations based on quoted prices for similar assets or liabilities in active markets, quoted prices for identical or similar assets or liabilities in markets that are not active, and models for which all significant inputs are observable, either directly or indirectly. </td> </tr> </table></div>   <div style="width:100%"><table cellpadding="0" cellspacing="0" style="border-collapse:collapse;width: 100.00%;CellSpacing:0;margin-left:0pt;"> <tr style="CellSpacing:0;"> <td valign="top" style="width:18.00pt;padding:0pt;">   </td> <td valign="top" style="width:18.00pt;padding:0pt;">   </td> <td valign="top" style="width:auto;padding:0pt 21.6pt 0pt 0pt;"> Level 3 — Valuations based on inputs that are unobservable and significant to the overall fair value measurement. </td> </tr> </table></div>   The determination of where an asset or liability falls in the hierarchy requires significant judgment.  The Company evaluates hierarchy disclosures and, based on various factors, it is possible that an asset or liability may be classified differently from period to period.  However, the Company expects that changes in classification between levels will be rare. <p style="margin:0pt 18pt 0pt 0pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;border-top:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;font-family:Times New Roman;font-size: 10pt">   There was no material re-measurement to fair value of financial assets and liabilities that are not measured at fair value on a recurring basis. <p style="margin:0pt 20.9pt 0pt 0pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;border-top:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;font-family:Times New Roman;font-size: 10pt">   Below is a table that presents information about certain assets and liabilities measured at fair value on a recurring basis:   <div style="width:100%"><table cellpadding="0" cellspacing="0" style="border-collapse:collapse;width: 100.76%;margin-left:0pt;"> <tr> <td valign="bottom" style="width:117.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:04.50pt;padding:0pt 0pt 1.2pt 0pt;">   </td> <td valign="bottom" style="width:09.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:76.60pt;padding:0pt;">   </td> <td valign="bottom" style="width:03.25pt;padding:0pt 0pt 1.2pt 0pt;">   </td> <td valign="bottom" style="width:03.25pt;padding:0pt 0pt 1.2pt 0pt;">   </td> <td valign="bottom" style="width:05.00pt;border-bottom:1pt solid #000000 ;padding:0pt;">   </td> <td valign="bottom" style="width:78.40pt;border-bottom:1pt solid #000000 ;padding:0pt;">   </td> <td valign="bottom" style="width:04.50pt;border-bottom:1pt solid #000000 ;padding:0pt;">   </td> <td valign="bottom" style="width:02.20pt;border-bottom:1pt solid #000000 ;padding:0pt;">   </td> <td valign="bottom" style="width:05.40pt;border-bottom:1pt solid #000000 ;padding:0pt;">   </td> <td valign="bottom" style="width:66.95pt;border-bottom:1pt solid #000000 ;padding:0pt;">   </td> <td valign="bottom" style="width:02.45pt;border-bottom:1pt solid #000000 ;padding:0pt;">   </td> <td valign="bottom" style="width:02.55pt;border-bottom:1pt solid #000000 ;padding:0pt;">   </td> <td valign="bottom" style="width:10.50pt;border-bottom:1pt solid #000000 ;padding:0pt 0pt 1.2pt 0pt;">   </td> <td valign="bottom" style="width:80.00pt;border-bottom:1pt solid #000000 ;padding:0pt;">   </td> </tr> <tr> <td valign="bottom" style="width:117.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:04.50pt;padding:0pt 0pt 1.2pt 0pt;">   </td> <td colspan="2" valign="bottom" style="width:85.60pt;padding:0pt;">   </td> <td valign="bottom" style="width:03.25pt;padding:0pt 0pt 1.2pt 0pt;">   </td> <td valign="bottom" style="width:03.25pt;padding:0pt 0pt 1.2pt 0pt;">   </td> <td colspan="8" valign="bottom" style="width:167.45pt;border-top:1pt solid #000000 ;border-bottom:1pt solid #000000 ;padding:0pt;"> Fair Value Measurements at June 30, 2014 </td> <td colspan="2" valign="bottom" style="width:90.50pt;border-top:1pt solid #000000 ;border-bottom:1pt solid #000000 ;padding:0pt 0pt 1.2pt 0pt;">   </td> </tr> <tr> <td valign="bottom" style="width:117.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:04.50pt;padding:0pt 0pt 1.2pt 0pt;">   </td> <td colspan="2" valign="bottom" style="width:85.60pt;border-bottom:1pt solid #000000 ;padding:0pt;"> June 30, 2014 </td> <td valign="bottom" style="width:03.25pt;padding:0pt 0pt 1.2pt 0pt;">   </td> <td valign="bottom" style="width:03.25pt;padding:0pt 0pt 1.2pt 0pt;">   </td> <td colspan="2" valign="bottom" style="width:83.40pt;border-bottom:1pt solid #000000 ;padding:0pt;"> Quoted Prices in Active Markets for Identical Assets (Level 1) </td> <td valign="bottom" style="width:04.50pt;padding:0pt 0pt 1.2pt 0pt;">   </td> <td valign="bottom" style="width:02.20pt;padding:0pt;">   </td> <td valign="bottom" style="width:05.40pt;padding:0pt 0pt 1.2pt 0pt;">   </td> <td valign="bottom" style="width:66.95pt;border-bottom:1pt solid #000000 ;padding:0pt;"> Significant Other Observable Inputs (Level 2) </td> <td valign="bottom" style="width:02.45pt;padding:0pt 0pt 1.2pt 0pt;">   </td> <td valign="bottom" style="width:02.55pt;padding:0pt 0pt 1.2pt 0pt;">   </td> <td colspan="2" valign="bottom" style="width:90.50pt;border-top:1pt solid #000000 ;border-bottom:1pt solid #000000 ;padding:0pt;"> Significant Unobservable Inputs (Level 3) </td> </tr> <tr> <td valign="bottom" style="width:117.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:04.50pt;padding:0pt;">   </td> <td colspan="12" valign="bottom" style="width:259.55pt;padding:0pt;"> (in thousands) </td> <td colspan="2" valign="bottom" style="width:90.50pt;padding:0pt;">   </td> </tr> <tr> <td valign="bottom" style="width:117.00pt;background-color: #CCFFCC;padding:0pt 0pt 0pt 12pt;"> Cash equivalents </td> <td valign="bottom" style="width:04.50pt;background-color: #CCFFCC;padding:0pt;">   </td> <td valign="bottom" style="width:09.00pt;background-color: #CCFFCC;padding:0pt;"> $ </td> <td valign="bottom" style="width:76.60pt;background-color: #CCFFCC;;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>118,228  </td> <td valign="bottom" style="width:03.25pt;background-color: #CCFFCC;padding:0pt;">   </td> <td valign="bottom" style="width:03.25pt;background-color: #CCFFCC;padding:0pt;">   </td> <td valign="bottom" style="width:05.00pt;background-color: #CCFFCC;padding:0pt;"> $ </td> <td valign="bottom" style="width:78.40pt;background-color: #CCFFCC;;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>118,228  </td> <td valign="bottom" style="width:04.50pt;background-color: #CCFFCC;padding:0pt;">   </td> <td valign="bottom" style="width:02.20pt;background-color: #CCFFCC;padding:0pt;">   </td> <td valign="bottom" style="width:05.40pt;background-color: #CCFFCC;padding:0pt;"> $ </td> <td valign="bottom" style="width:66.95pt;background-color: #CCFFCC;padding:0pt;"> — </td> <td valign="bottom" style="width:02.45pt;background-color: #CCFFCC;padding:0pt;">   </td> <td valign="bottom" style="width:02.55pt;background-color: #CCFFCC;padding:0pt;">   </td> <td valign="bottom" style="width:10.50pt;background-color: #CCFFCC;padding:0pt;"> $ </td> <td valign="bottom" style="width:80.00pt;background-color: #CCFFCC;padding:0pt;"> — </td> </tr> <tr> <td valign="bottom" style="width:117.00pt;background-color: #FFFFFF;padding:0pt 0pt 0pt 12pt;"> Short-term investments </td> <td valign="bottom" style="width:04.50pt;background-color: #FFFFFF;padding:0pt;">   </td> <td valign="bottom" style="width:09.00pt;background-color: #FFFFFF;padding:0pt;">   </td> <td valign="bottom" style="width:76.60pt;background-color: #FFFFFF;;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>80,996  </td> <td valign="bottom" style="width:03.25pt;background-color: #FFFFFF;padding:0pt;">   </td> <td valign="bottom" style="width:03.25pt;background-color: #FFFFFF;padding:0pt;">   </td> <td valign="bottom" style="width:05.00pt;background-color: #FFFFFF;padding:0pt;">   </td> <td valign="bottom" style="width:78.40pt;background-color: #FFFFFF;padding:0pt;"> — </td> <td valign="bottom" style="width:04.50pt;background-color: #FFFFFF;padding:0pt;">   </td> <td valign="bottom" style="width:02.20pt;background-color: #FFFFFF;padding:0pt;">   </td> <td valign="bottom" style="width:05.40pt;background-color: #FFFFFF;padding:0pt;">   </td> <td valign="bottom" style="width:66.95pt;background-color: #FFFFFF;;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>80,996  </td> <td valign="bottom" style="width:02.45pt;background-color: #FFFFFF;padding:0pt;">   </td> <td valign="bottom" style="width:02.55pt;background-color: #FFFFFF;padding:0pt;">   </td> <td valign="bottom" style="width:10.50pt;background-color: #FFFFFF;padding:0pt;">   </td> <td valign="bottom" style="width:80.00pt;background-color: #FFFFFF;padding:0pt;"> — </td> </tr> </table></div>   <div style="width:100%"><table cellpadding="0" cellspacing="0" style="border-collapse:collapse;width: 100.96%;margin-left:0pt;"> <tr> <td valign="bottom" style="width:126.10pt;padding:0pt;">   </td> <td valign="bottom" style="width:02.25pt;padding:0pt 0pt 1.2pt 0pt;">   </td> <td colspan="2" valign="bottom" style="width:06.65pt;padding:0pt;">   </td> <td valign="bottom" style="width:71.30pt;padding:0pt;">   </td> <td valign="bottom" style="width:03.50pt;padding:0pt 0pt 1.2pt 0pt;">   </td> <td colspan="2" valign="bottom" style="width:05.80pt;padding:0pt 0pt 1.2pt 0pt;">   </td> <td colspan="2" valign="bottom" style="width:13.45pt;border-bottom:1pt solid #000000 ;padding:0pt;">   </td> <td valign="bottom" style="width:71.80pt;border-bottom:1pt solid #000000 ;padding:0pt;">   </td> <td colspan="2" valign="bottom" style="width:04.55pt;border-bottom:1pt solid #000000 ;padding:0pt;">   </td> <td colspan="2" valign="bottom" style="width:04.55pt;border-bottom:1pt solid #000000 ;padding:0pt;">   </td> <td colspan="2" valign="bottom" style="width:04.50pt;border-bottom:1pt solid #000000 ;padding:0pt;">   </td> <td colspan="2" valign="bottom" style="width:58.70pt;border-bottom:1pt solid #000000 ;padding:0pt;">   </td> <td valign="bottom" style="width:04.50pt;border-bottom:1pt solid #000000 ;padding:0pt;">   </td> <td colspan="2" valign="bottom" style="width:04.50pt;border-bottom:1pt solid #000000 ;padding:0pt;">   </td> <td valign="bottom" style="width:09.20pt;border-bottom:1pt solid #000000 ;padding:0pt;">   </td> <td valign="bottom" style="width:76.60pt;border-bottom:1pt solid #000000 ;padding:0pt;">   </td> <td colspan="2" valign="bottom" style="width:04.55pt;padding:0pt 0pt 1.2pt 0pt;">   </td> </tr> <tr> <td valign="bottom" style="width:126.10pt;padding:0pt;">   </td> <td valign="bottom" style="width:02.25pt;padding:0pt 0pt 1.2pt 0pt;">   </td> <td colspan="3" valign="bottom" style="width:77.95pt;padding:0pt;">   </td> <td valign="bottom" style="width:03.50pt;padding:0pt 0pt 1.2pt 0pt;">   </td> <td colspan="2" valign="bottom" style="width:05.80pt;padding:0pt 0pt 1.2pt 0pt;">   </td> <td colspan="14" valign="bottom" style="width:166.55pt;border-bottom:1pt solid #000000 ;padding:0pt;"> Fair Value Measurements at December 31, 2013 </td> <td colspan="2" valign="bottom" style="width:85.80pt;border-bottom:1pt solid #000000 ;padding:0pt;">   </td> <td valign="bottom" style="width:03.95pt;padding:0pt 0pt 1.2pt 0pt;">   </td> </tr> <tr> <td valign="bottom" style="width:126.10pt;padding:0pt;">   </td> <td valign="bottom" style="width:02.25pt;padding:0pt 0pt 1.2pt 0pt;">   </td> <td colspan="3" valign="bottom" style="width:77.95pt;border-bottom:1pt solid #000000 ;padding:0pt;"> December 31, 2013 </td> <td valign="bottom" style="width:03.50pt;padding:0pt 0pt 1.2pt 0pt;">   </td> <td colspan="2" valign="bottom" style="width:05.80pt;padding:0pt 0pt 1.2pt 0pt;">   </td> <td colspan="6" valign="bottom" style="width:90.30pt;border-bottom:1pt solid #000000 ;padding:0pt;"> Quoted Prices in Active Markets for Identical Assets (Level 1) </td> <td colspan="2" valign="bottom" style="width:04.50pt;padding:0pt 0pt 1.2pt 0pt;">   </td> <td colspan="2" valign="bottom" style="width:04.50pt;padding:0pt 0pt 1.2pt 0pt;">   </td> <td valign="bottom" style="width:58.25pt;border-bottom:1pt solid #000000 ;padding:0pt;"> Significant Other Observable Inputs (Level 2) </td> <td colspan="2" valign="bottom" style="width:05.25pt;padding:0pt 0pt 1.2pt 0pt;">   </td> <td valign="bottom" style="width:03.75pt;padding:0pt 0pt 1.2pt 0pt;">   </td> <td colspan="2" valign="bottom" style="width:85.80pt;border-bottom:1pt solid #000000 ;padding:0pt;"> Significant Unobservable Inputs (Level 3) </td> <td valign="bottom" style="width:03.95pt;padding:0pt 0pt 1.2pt 0pt;">   </td> </tr> <tr> <td valign="bottom" style="width:126.10pt;padding:0pt;">   </td> <td valign="bottom" style="width:02.25pt;padding:0pt;">   </td> <td colspan="20" valign="bottom" style="width:253.80pt;padding:0pt;"> (in thousands) </td> <td colspan="2" valign="bottom" style="width:85.80pt;padding:0pt;">   </td> <td valign="bottom" style="width:03.95pt;padding:0pt;">   </td> </tr> <tr> <td valign="bottom" style="width:126.10pt;background-color: #CCFFCC;padding:0pt 0pt 0pt 12pt;"> Cash equivalents </td> <td valign="bottom" style="width:02.25pt;background-color: #CCFFCC;padding:0pt;">   </td> <td valign="bottom" style="width:04.85pt;background-color: #CCFFCC;padding:0pt;"> $ </td> <td colspan="2" valign="bottom" style="width:73.10pt;background-color: #CCFFCC;;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>107,349  </td> <td colspan="2" valign="bottom" style="width:04.75pt;background-color: #CCFFCC;padding:0pt;">   </td> <td valign="bottom" style="width:04.55pt;background-color: #CCFFCC;padding:0pt;">   </td> <td valign="bottom" style="width:09.95pt;background-color: #CCFFCC;padding:0pt;"> $ </td> <td colspan="3" valign="bottom" style="width:75.85pt;background-color: #CCFFCC;;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>107,349  </td> <td colspan="2" valign="bottom" style="width:04.50pt;background-color: #CCFFCC;padding:0pt;">   </td> <td colspan="2" valign="bottom" style="width:04.50pt;background-color: #CCFFCC;padding:0pt;">   </td> <td colspan="2" valign="bottom" style="width:04.50pt;background-color: #CCFFCC;padding:0pt;"> $ </td> <td valign="bottom" style="width:58.25pt;background-color: #CCFFCC;padding:0pt;"> — </td> <td colspan="2" valign="bottom" style="width:05.25pt;background-color: #CCFFCC;padding:0pt;">   </td> <td valign="bottom" style="width:03.75pt;background-color: #CCFFCC;padding:0pt;">   </td> <td valign="bottom" style="width:09.20pt;background-color: #CCFFCC;padding:0pt;"> $ </td> <td valign="bottom" style="width:76.60pt;background-color: #CCFFCC;padding:0pt;"> — </td> <td colspan="2" valign="bottom" style="width:04.55pt;background-color: #CCFFCC;padding:0pt;">   </td> </tr> </table></div>   Short-term investments consist of corporate bonds, commercial paper and certificates of deposit.   Revenue Recognition The Company’s revenues generally consist of revenue generated under federal contracts. Revenues are recognized when the following criteria are met: (1) persuasive evidence that an arrangement exists; (2) delivery of the products and/or services has occurred; (3) the selling price is fixed or determinable; and (4) collectability is reasonably assured.    For arrangements that involve the delivery of more than one element, each product, service and/or right to use assets is evaluated to determine whether it qualifies as a separate unit of accounting. This determination is based on whether the deliverable has “stand-alone value” to the customer. The consideration that is fixed or determinable is then allocated to each separate unit of accounting based on the relative selling prices of each deliverable. The consideration allocated to each unit of accounting is recognized as the related goods and services are delivered, limited to the consideration that is not contingent upon future deliverables. If the arrangement constitutes a single unit of accounting, the revenue recognition policy must be determined for the entire arrangement and the consideration received is recognized over the period of inception through the date the last deliverable within the single unit of accounting is expected to be delivered. Revisions to the estimated period of recognition are reflected in revenue prospectively.    Non-refundable upfront fees are recorded as deferred revenue and recognized into revenue as license fees from collaborations on a straight-line basis over the estimated period of the Company’s substantive performance obligations.  If the Company does not have substantive performance obligations, the Company recognizes non-refundable upfront fees into revenue through the date the deliverable is satisfied.  Analyzing the arrangement to identify deliverables requires the use of judgment and each deliverable may be an obligation to deliver services, a right or license to use an asset, or another performance obligation.   Clinical Trial Accruals/Prepaids As part of the process of preparing financial statements, the Company is required to estimate its expenses resulting from its obligation under contracts with vendors and consultants and clinical site agreements in connection with conducting clinical trials. The financial terms of these contracts are subject to negotiations which vary contract to contract and may result in payment flows that do not match the periods over which materials or services are provided to the Company under such contracts. The Company’s objective is to reflect the appropriate clinical trial expenses in its financial statements by matching those expenses with the period in which services and efforts are expended. The Company accounts for these expenses according to the progress of the trial as measured by patient progression and the timing of various aspects of the trial. Depending on amounts paid to the contract research organization and other third-party vendors as compared to actual expenses incurred, there might be a prepaid balance recorded as a prepaid asset. The Company determines accrual estimates through discussion with applicable personnel and outside service providers as to the progress or state of completion of trials, or the services completed. During the course of a clinical trial, the Company adjusts its rate of clinical trial expense recognition if actual results differ from its estimates. The Company makes estimates of its accrued expenses as of each balance sheet date in its financial statements based on facts and circumstances known at that time. Although the Company does not expect its estimates to be materially different from amounts actually incurred, its understanding of status and timing of services performed relative to the actual status and timing of services performed may vary and may result in the Company reporting amounts that are too high or too low for any particular period. Through June 30, 2014, there had been no material adjustments to the Company’s prior period estimates of accrued expenses for clinical trials. The Company’s clinical trial accrual is dependent upon the timely and accurate reporting of contract research organizations and other third-party vendors.   Basic and Diluted Net Loss Per Common Share Basic net loss per share of common stock is computed by dividing net loss by the weighted-average number of shares of common stock outstanding during the period, excluding the dilutive effects of warrants and options to purchase common stock. Diluted net loss per common share is computed by dividing net loss by the sum of the weighted-average number of shares of common stock outstanding during the period plus the potential dilutive effects of warrants and options to purchase common stock outstanding during the period calculated in accordance with the treasury stock method, but are excluded if their effect is anti-dilutive. Because the impact of these items is anti-dilutive during the periods of net loss, there was no difference between basic and diluted loss per share of common stock for the three months ended or the six months ended June 30, 2014 and 2013.   The calculation of weighted-average diluted shares outstanding excludes the dilutive effect of warrants and options to purchase common stock, as the impact of such items are anti-dilutive during periods of net loss. Shares excluded from the calculations were 3,187,867 and 4,244,971 for the three months ended June 30, 2014 and 2013, respectively and 3,189,265 and 7,808,128 for the six months ended June 30, 2014 and 2013, respectively.    Impact of Recently Issued Accounting Standards During the quarter ended June 30, 2014, the Financial Accounting Standards Board (FASB) issued Accounting Standards Update No. 2014-09, “Revenue from Contracts with Customers” (Topic 606), which supersedes all existing revenue recognition requirements, including most industry-specific guidance. The new standard requires a company to recognize revenue when it transfers goods or services to customers in an amount that reflects the consideration that the company expects to receive for those goods or services. The new standard will be effective for the Company on January 1, 2017. The adoption of this standard is not expected to have an impact on the Company’s financial position or results of operations. </div> </div>

19906000

115438000

109976000

119601000

95532000

9625000

2011-02-07

7.26

41323

1433054

0.001

200000000

26664972

35404326

26664972

35404326

26000

35000

5300000

2579000

808000

1699000

5300000

919000

15556091

1613395

<div> <div style="margin-left:0pt;margin-right:0pt;"> 3. Loan Payable   On January 27, 2012, the Company entered into a Loan and Security Agreement (LSA) with Silicon Valley Bank (SVB) and MidCap Financial SBIC, LP (MidCap) allowing for borrowings up to $15.0 million, split between a first tranche of $3.0 million borrowed at the time of the agreement, and a second tranche of up to $12.0 million that would be available to be drawn by December 31, 2012 upon meeting one of three stated financial and/or operational goals. The borrowings under the LSA are collateralized by a security interest in all of the Company’s assets, excluding its intellectual property.    The first tranche was used to repay the remaining principal balance outstanding of $2.6 million under a previous loan.  This repayment was deemed a modification of debt and therefore the remaining related deferred financing costs totaling $0.1 million remained in deferred financing costs and are being amortized over the term of the LSA through interest expense.  The first tranche has an interest-only period of twelve months followed by a 30-month principal and interest amortization period with interest being charged at 8.25% per year for the full period of the LSA.   The Company met one of the financial and/or operational goals mentioned above and, in September 2012, the remaining $12.0 million was borrowed in the second tranche.  The second tranche has a six-month interest-only period followed by a 32 month principal and interest amortization period with interest being charged at the same rate as the first tranche.  There are certain fees in accordance with the LSA which are being recorded as discounts or other long and short-term liabilities depending on the nature of the fees.  The fees are being accreted through interest expense.  Approximately $24,000 and $37,000 was included in interest expense for the three months ended June 30, 2014 and 2013, respectively, and $51,000 and $75,000 for the six months ended June 30, 2014 and 2013, respectively.   Concurrently with entering into the LSA, the Company also granted SVB a warrant to purchase shares of Series F preferred stock. Upon the completion of the Company’s IPO, this warrant was converted into a warrant to purchase 41,323 shares of common stock. In May 2013, SVB exercised the warrant in full and it is no longer outstanding. </div> </div>

10000

6000

20000

100000

0.15

30000

32000

135000

95000

-4.50

-0.91

-0.78

-0.39

0.00

149000

47000

14184

970874

6400000

4300000

<div> <div style="margin-left:0pt;margin-right:0pt;"> 6. Income Taxes   The Company estimates an annual effective tax rate of 0% for the year ending December 31, 2014 as the Company incurred losses for the six month period ended June 30, 2014 and is forecasting additional losses through the 4th quarter, resulting in an estimated net loss for both financial statement and tax purposes for the year ending December 31, 2014. Therefore, no federal or state income taxes are expected and none have been recorded at this time. Income taxes have been accounted for using the liability method in accordance with FASB Accounting Standards Codification 740.   Due to the Company's history of losses since inception, there is not enough evidence at this time to support that the Company will generate future income of a sufficient amount and nature to utilize the benefits of its net deferred tax assets. Accordingly, the deferred tax assets have been reduced by a full valuation allowance, since the Company does not currently believe that realization of its deferred tax assets is more likely than not.   At June 30, 2014, the Company had no unrecognized tax benefits that would reduce the Company’s effective tax rate if recognized. </div> </div>

-400000

1912000

-700000

40000

2051000

489000

771000

75000

415000

37000

334000

51000

138000

24000

505000

370000

<div> <div style="margin-left:0pt;margin-right:0pt;"> 2. Investments   The following table summarizes available-for-sale securities:   <div style="width:100%"><table cellpadding="0" cellspacing="0" style="border-collapse:collapse;width: 100.84%;margin-left:0pt;"> <tr> <td valign="bottom" style="width:auto;padding:0pt;">   </td> <td valign="bottom" style="width:auto;padding:0pt 0pt 1.2pt 0pt;">   </td> <td valign="bottom" style="width:auto;border-bottom:1pt solid #000000 ;padding:0pt;">   </td> <td valign="bottom" style="width:auto;border-bottom:1pt solid #000000 ;padding:0pt;">   </td> <td valign="bottom" style="width:00.52%;border-bottom:1pt solid #000000 ;padding:0pt;">   </td> <td valign="bottom" style="width:01.10%;border-bottom:1pt solid #000000 ;padding:0pt;">   </td> <td valign="bottom" style="width:01.08%;border-bottom:1pt solid #000000 ;padding:0pt;">   </td> <td valign="bottom" style="width:16.34%;border-bottom:1pt solid #000000 ;padding:0pt;">   </td> <td valign="bottom" style="width:00.52%;border-bottom:1pt solid #000000 ;padding:0pt;">   </td> <td valign="bottom" style="width:01.44%;border-bottom:1pt solid #000000 ;padding:0pt;">   </td> <td valign="bottom" style="width:01.08%;border-bottom:1pt solid #000000 ;padding:0pt;">   </td> <td valign="bottom" style="width:17.80%;border-bottom:1pt solid #000000 ;padding:0pt;">   </td> <td colspan="2" valign="bottom" style="width:01.80%;border-bottom:1pt solid #000000 ;padding:0pt;">   </td> <td valign="bottom" style="width:00.22%;border-bottom:1pt solid #000000 ;padding:0pt;">   </td> <td valign="bottom" style="width:01.28%;border-bottom:1pt solid #000000 ;padding:0pt;">   </td> <td colspan="2" valign="bottom" style="width:13.78%;border-bottom:1pt solid #000000 ;padding:0pt;">   </td> <td valign="bottom" style="width:00.52%;padding:0pt 0pt 1.2pt 0pt;">   </td> </tr> <tr> <td valign="bottom" style="width:auto;padding:0pt;">   </td> <td valign="bottom" style="width:auto;padding:0pt 0pt 1.2pt 0pt;">   </td> <td colspan="16" valign="bottom" style="width:71.96%;border-bottom:1pt solid #000000 ;padding:0pt;"> June 30, 2014 </td> <td valign="bottom" style="width:00.52%;padding:0pt 0pt 1.2pt 0pt;">   </td> </tr> <tr> <td valign="bottom" style="width:auto;padding:0pt;">   </td> <td valign="bottom" style="width:auto;padding:0pt 0pt 1.2pt 0pt;">   </td> <td colspan="2" valign="bottom" style="width:auto;border-bottom:1pt solid #000000 ;padding:0pt;"> Amortized Cost </td> <td valign="bottom" style="width:00.52%;padding:0pt 0pt 1.2pt 0pt;">   </td> <td valign="bottom" style="width:01.10%;padding:0pt 0pt 1.2pt 0pt;">   </td> <td colspan="2" valign="bottom" style="width:17.40%;border-bottom:1pt solid #000000 ;padding:0pt;"> Gross Unrealized Gains </td> <td valign="bottom" style="width:00.52%;padding:0pt 0pt 1.2pt 0pt;">   </td> <td valign="bottom" style="width:01.44%;padding:0pt 0pt 1.2pt 0pt;">   </td> <td colspan="2" valign="bottom" style="width:18.88%;border-bottom:1pt solid #000000 ;padding:0pt;"> Gross Unrealized Losses </td> <td colspan="3" valign="bottom" style="width:02.02%;padding:0pt 0pt 1.2pt 0pt;">   </td> <td valign="bottom" style="width:01.28%;padding:0pt 0pt 1.2pt 0pt;">   </td> <td colspan="2" valign="bottom" style="width:13.78%;border-bottom:1pt solid #000000 ;padding:0pt;"> Estimated Fair Value </td> <td valign="bottom" style="width:00.52%;padding:0pt 0pt 1.2pt 0pt;">   </td> </tr> <tr> <td valign="bottom" style="width:auto;padding:0pt;">   </td> <td valign="bottom" style="width:auto;padding:0pt;">   </td> <td colspan="16" valign="bottom" style="width:71.96%;padding:0pt;"> (in thousands) </td> <td valign="bottom" style="width:00.52%;padding:0pt;">   </td> </tr> <tr> <td valign="bottom" style="width:26.98%;background-color: #CCFFCC;padding:0pt 0pt 0pt 12pt;"> Corporate bonds </td> <td valign="bottom" style="width:00.52%;background-color: #CCFFCC;padding:0pt;">   </td> <td valign="bottom" style="width:01.08%;background-color: #CCFFCC;padding:0pt;"> $ </td> <td valign="bottom" style="width:13.94%;background-color: #CCFFCC;;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>49,992 </td> <td valign="bottom" style="width:00.52%;background-color: #CCFFCC;padding:0pt;">   </td> <td valign="bottom" style="width:01.10%;background-color: #CCFFCC;padding:0pt;">   </td> <td valign="bottom" style="width:01.08%;background-color: #CCFFCC;padding:0pt;"> $ </td> <td valign="bottom" style="width:16.34%;background-color: #CCFFCC;;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>1 </td> <td valign="bottom" style="width:00.52%;background-color: #CCFFCC;padding:0pt;">   </td> <td valign="bottom" style="width:01.44%;background-color: #CCFFCC;padding:0pt;">   </td> <td valign="bottom" style="width:01.08%;background-color: #CCFFCC;padding:0pt;"> $ </td> <td valign="bottom" style="width:17.80%;background-color: #CCFFCC;;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>(18 </td> <td valign="bottom" style="width:00.88%;background-color: #CCFFCC;"> ) </td> <td colspan="3" valign="bottom" style="width:02.42%;background-color: #CCFFCC;padding:0pt;">   </td> <td valign="bottom" style="width:01.08%;background-color: #CCFFCC;padding:0pt;"> $ </td> <td valign="bottom" style="width:12.70%;background-color: #CCFFCC;;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>49,975 </td> <td valign="bottom" style="width:00.52%;background-color: #CCFFCC;padding:0pt;">   </td> </tr> <tr> <td valign="bottom" style="width:auto;background-color: #FFFFFF;padding:0pt 0pt 1.2pt 12pt;"> Commercial paper </td> <td valign="bottom" style="width:auto;background-color: #FFFFFF;padding:0pt 0pt 1.2pt 0pt;">   </td> <td valign="bottom" style="width:auto;background-color: #FFFFFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;background-color: #FFFFFF;;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>26,224 </td> <td valign="bottom" style="width:00.52%;background-color: #FFFFFF;padding:0pt 0pt 1.2pt 0pt;">   </td> <td valign="bottom" style="width:01.10%;background-color: #FFFFFF;padding:0pt 0pt 1.2pt 0pt;">   </td> <td valign="bottom" style="width:01.08%;background-color: #FFFFFF;padding:0pt;">   </td> <td valign="bottom" style="width:16.34%;background-color: #FFFFFF;;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>5 </td> <td valign="bottom" style="width:00.52%;background-color: #FFFFFF;padding:0pt 0pt 1.2pt 0pt;">   </td> <td valign="bottom" style="width:01.44%;background-color: #FFFFFF;padding:0pt 0pt 1.2pt 0pt;">   </td> <td valign="bottom" style="width:01.08%;background-color: #FFFFFF;padding:0pt;">   </td> <td valign="bottom" style="width:17.80%;background-color: #FFFFFF;;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>(4 </td> <td valign="bottom" style="width:00.88%;background-color: #FFFFFF;"> ) </td> <td colspan="3" valign="bottom" style="width:02.42%;background-color: #FFFFFF;padding:0pt 0pt 1.2pt 0pt;">   </td> <td valign="bottom" style="width:01.08%;background-color: #FFFFFF;padding:0pt;">   </td> <td valign="bottom" style="width:12.70%;background-color: #FFFFFF;;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>26,225 </td> <td valign="bottom" style="width:00.52%;background-color: #FFFFFF;padding:0pt 0pt 1.2pt 0pt;">   </td> </tr> <tr> <td valign="bottom" style="width:auto;background-color: #CCFFCC;padding:0pt 0pt 3pt 12pt;"> Certificates of deposit </td> <td valign="bottom" style="width:auto;background-color: #CCFFCC;padding:0pt 0pt 3pt 0pt;">   </td> <td valign="bottom" style="width:auto;border-bottom:1pt solid #000000 ;background-color: #CCFFCC;padding:0pt;">   </td> <td valign="bottom" style="width:auto;border-bottom:1pt solid #000000 ;background-color: #CCFFCC;;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>4,800 </td> <td valign="bottom" style="width:00.52%;background-color: #CCFFCC;padding:0pt 0pt 3pt 0pt;">   </td> <td valign="bottom" style="width:01.10%;background-color: #CCFFCC;padding:0pt 0pt 3pt 0pt;">   </td> <td valign="bottom" style="width:01.08%;border-bottom:1pt solid #000000 ;background-color: #CCFFCC;padding:0pt;">   </td> <td valign="bottom" style="width:16.34%;border-bottom:1pt solid #000000 ;background-color: #CCFFCC;padding:0pt;"> — </td> <td valign="bottom" style="width:00.52%;background-color: #CCFFCC;padding:0pt 0pt 3pt 0pt;">   </td> <td valign="bottom" style="width:01.44%;background-color: #CCFFCC;padding:0pt 0pt 3pt 0pt;">   </td> <td valign="bottom" style="width:01.08%;border-bottom:1pt solid #000000 ;background-color: #CCFFCC;padding:0pt;">   </td> <td valign="bottom" style="width:17.80%;border-bottom:1pt solid #000000 ;background-color: #CCFFCC;;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>(4 </td> <td valign="bottom" style="width:00.88%;background-color: #CCFFCC;"> ) </td> <td colspan="3" valign="bottom" style="width:02.42%;background-color: #CCFFCC;padding:0pt 0pt 3pt 0pt;">   </td> <td valign="bottom" style="width:01.08%;border-bottom:1pt solid #000000 ;background-color: #CCFFCC;padding:0pt;">   </td> <td valign="bottom" style="width:12.70%;border-bottom:1pt solid #000000 ;background-color: #CCFFCC;;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>4,796 </td> <td valign="bottom" style="width:00.52%;background-color: #CCFFCC;padding:0pt 0pt 3pt 0pt;">   </td> </tr> <tr> <td valign="bottom" style="width:auto;background-color: #CCFFCC;padding:0pt 0pt 3pt 12pt;"> Total </td> <td valign="bottom" style="width:auto;background-color: #CCFFCC;padding:0pt 0pt 3pt 0pt;">   </td> <td valign="bottom" style="width:auto;border-top:1pt solid #000000 ;border-bottom:2pt double #000000 ;background-color: #CCFFCC;padding:0pt;"> $ </td> <td valign="bottom" style="width:auto;border-top:1pt solid #000000 ;border-bottom:2pt double #000000 ;background-color: #CCFFCC;;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>81,016 </td> <td valign="bottom" style="width:00.52%;background-color: #CCFFCC;padding:0pt 0pt 3pt 0pt;">   </td> <td valign="bottom" style="width:01.10%;background-color: #CCFFCC;padding:0pt 0pt 3pt 0pt;">   </td> <td valign="bottom" style="width:01.08%;border-top:1pt solid #000000 ;border-bottom:2pt double #000000 ;background-color: #CCFFCC;padding:0pt;"> $ </td> <td valign="bottom" style="width:16.34%;border-top:1pt solid #000000 ;border-bottom:2pt double #000000 ;background-color: #CCFFCC;;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>6 </td> <td valign="bottom" style="width:00.52%;background-color: #CCFFCC;padding:0pt 0pt 3pt 0pt;">   </td> <td valign="bottom" style="width:01.44%;background-color: #CCFFCC;padding:0pt 0pt 3pt 0pt;">   </td> <td valign="bottom" style="width:01.08%;border-top:1pt solid #000000 ;border-bottom:2pt double #000000 ;background-color: #CCFFCC;padding:0pt;"> $ </td> <td valign="bottom" style="width:17.80%;border-top:1pt solid #000000 ;border-bottom:2pt double #000000 ;background-color: #CCFFCC;;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>(26 </td> <td valign="bottom" style="width:00.88%;background-color: #CCFFCC;"> ) </td> <td colspan="3" valign="bottom" style="width:02.42%;background-color: #CCFFCC;padding:0pt 0pt 3pt 0pt;">   </td> <td valign="bottom" style="width:01.08%;border-top:1pt solid #000000 ;border-bottom:2pt double #000000 ;background-color: #CCFFCC;padding:0pt;"> $ </td> <td valign="bottom" style="width:12.70%;border-top:1pt solid #000000 ;border-bottom:2pt double #000000 ;background-color: #CCFFCC;;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>80,996 </td> <td valign="bottom" style="width:00.52%;background-color: #CCFFCC;padding:0pt 0pt 3pt 0pt;">   </td> </tr> </table></div>     The Company had no short or long-term investments at December 31, 2013. All of the Company’s investments as of June 30, 2014 had maturities of one year or less at the time of purchase. </div> </div>

14848000

13983000

113387000

204658000

10207000

12218000

3000000

0.0825

15000000

12000000

5573000

5610000

107126000

110005000

2036000

-81627000

-13630000

-18753000

-55674000

-21041000

-22114000

-11734000

-14205000

-7656000

-21780000

-11596000

200000

100000

300000

200000

<div> <div style="margin-left:0pt;margin-right:0pt;"> Description of Business Chimerix, Inc. (the Company) is a biopharmaceutical company dedicated to discovering, developing and commercializing novel, oral antivirals to address unmet medical needs. The Company was founded in 2000 based on the promise of its proprietary lipid technology to unlock the potential of some of the most potent antivirals by enhancing their antiviral activity and safety profiles in convenient, orally administered dosing regimens. Based on the Company’s proprietary lipid technology, its lead compound, brincidofovir (BCV, CMX001), is in Phase 3 clinical development; in addition, the Company has an active discovery program focusing on viral targets for which no therapies are currently available.   On March 25, 2013, the Company’s board of directors approved and implemented a 3.55-for-1 reverse split of the Company’s outstanding common stock. The accompanying financial statements and notes to the financial statements give retroactive effect to the reverse stock split for all periods presented. <p style="margin:0pt 18pt 0pt 0pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;border-top:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;font-family:Times New Roman;font-size: 10pt">   On April 10, 2013, the Company completed the initial public offering (IPO) of its common stock pursuant to a registration statement on Form S-1. In the IPO, the Company sold an aggregate of 7,320,000 shares of common stock under the registration statement at a public offering price of $14.00 per share. Net proceeds were approximately $93.3 million, after deducting underwriting discounts and commissions of $7.1 million and offering expenses of $2.1 million. Upon the completion of the IPO, all outstanding shares of the Company’s redeemable convertible preferred stock and dividends accrued on Series F redeemable convertible preferred stock were converted into 15,556,091 shares of common stock and all outstanding warrants to purchase redeemable convertible preferred stock were converted into warrants to purchase 1,613,395 shares of common stock.  On April 16, 2013, the underwriters exercised the full over-allotment option pursuant to which the Company sold an additional 1,098,000 shares of common stock at $14.00 per share. Net proceeds from the over-allotment shares were approximately $14.3 million after deducting underwriting discounts and commissions of $1.1 million.   On October 23, 2013, the Company completed an underwritten secondary public offering of 2,476,995 shares of common stock held by certain of the Company’s existing stockholders at a price to the public of $16.50 per share. The Company did not issue any shares of common stock and received no proceeds in connection with such offering. The principal purposes of the offering were to facilitate an orderly distribution of shares and to increase the Company’s public float.   On May 27, 2014, the Company completed an underwritten public offering of 8,395,000 shares of common stock, including 1,095,000 shares sold pursuant to the full exercise of an over-allotment option previously granted to the underwriters. All of the shares were offered by the Company at a price to the public of $14.22 per share. Net proceeds to the Company from this offering, after deducting underwriting discounts and commissions and other offering expenses payable by the Company, were approximately $111.8 million. The securities described above were offered by the Company pursuant to a shelf registration statement declared effective by the Securities and Exchange Commission (the SEC) on May 16, 2014.   The accompanying unaudited financial statements have been prepared in accordance with U.S. generally accepted accounting principles, or GAAP, for interim financial information, the instructions to Form 10-Q and Article 10 of Regulation S-X. Accordingly, they do not include all of the information and footnotes required by GAAP for complete financial statements and should be read in conjunction with the Company’s audited financial statements and notes thereto included in its Annual Report on Form 10-K for the year ended December 31, 2013.  In the opinion of the Company’s management, all adjustments, consisting of normal recurring adjustments, necessary for a fair presentation of its financial position, operating results and cash flows for the periods presented have been included.  Operating results for the three and six months ended June 30, 2014 are not necessarily indicative of the results that may be expected for the full year, for any other interim period or for any future year.  </div> </div>

-21565000

-12458000

-22134000

-11722000

347000

285000

2600000

2100000

70000

226000

1851000

88641000

34108000

8582000

0.001

10000000

2765000

3246000

93300000

111800000

107634000

111845000

1537000

3957000

7240000

55000

781000

229000

-21566000

-12459000

-22114000

-11734000

338000

469000

75800000

2100000

2850000

13059000

6276000

16384000

8092000

-162730000

-184844000

2579000

808000

1699000

919000

<div> <div style="margin-left:0pt;margin-right:0pt;"> Compensation expense recognized related to stock options, RSUs and the ESPP is as follows:   <div style="width:100%"><table cellpadding="0" cellspacing="0" style="border-collapse:collapse;margin-left:0pt;"> <tr> <td valign="bottom" style="width:37.14%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="top" style="width:00.78%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td colspan="6" valign="top" style="width:28.68%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> Three Months Ended June 30, </td> <td valign="bottom" style="width:00.94%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt 0pt 1.2pt 0pt;">   </td> <td colspan="6" valign="bottom" style="width:31.94%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> Six Months Ended June 30, </td> <td valign="bottom" style="width:00.52%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt 0pt 1.2pt 0pt;">   </td> </tr> <tr> <td valign="bottom" style="width:37.14%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="top" style="width:00.78%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td colspan="2" valign="top" style="width:14.38%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> 2014 </td> <td valign="top" style="width:00.76%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="top" style="width:00.78%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td colspan="2" valign="top" style="width:12.78%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> 2013 </td> <td valign="bottom" style="width:00.94%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt 0pt 1.2pt 0pt;">   </td> <td colspan="2" valign="bottom" style="width:15.02%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> 2014 </td> <td valign="bottom" style="width:00.94%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt 0pt 1.2pt 0pt;">   </td> <td valign="bottom" style="width:00.94%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt 0pt 1.2pt 0pt;">   </td> <td colspan="2" valign="bottom" style="width:15.06%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> 2013 </td> <td valign="bottom" style="width:00.52%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt 0pt 1.2pt 0pt;">   </td> </tr> <tr> <td valign="bottom" style="width:37.14%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="top" style="width:00.78%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td colspan="6" valign="top" style="width:28.68%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> (in thousands) </td> <td valign="bottom" style="width:00.94%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td colspan="6" valign="bottom" style="width:31.94%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> (in thousands) </td> <td valign="bottom" style="width:00.52%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> </tr> <tr> <td valign="bottom" style="width:37.14%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFCC;padding:0pt 0pt 0pt 12pt;"> Research and development: </td> <td valign="top" style="width:00.78%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFCC;padding:0pt;">   </td> <td valign="top" style="width:00.96%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFCC;padding:0pt;">   </td> <td valign="top" style="width:13.42%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFCC;padding:0pt;">   </td> <td valign="top" style="width:00.76%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFCC;padding:0pt;">   </td> <td valign="top" style="width:00.78%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFCC;padding:0pt;">   </td> <td valign="top" style="width:00.96%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFCC;padding:0pt;">   </td> <td valign="top" style="width:11.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFCC;padding:0pt;">   </td> <td valign="bottom" style="width:00.94%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFCC;padding:0pt;">   </td> <td valign="bottom" style="width:00.96%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFCC;padding:0pt;">   </td> <td valign="bottom" style="width:14.04%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFCC;padding:0pt;">   </td> <td valign="bottom" style="width:00.94%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFCC;padding:0pt;">   </td> <td valign="bottom" style="width:00.94%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFCC;padding:0pt;">   </td> <td valign="bottom" style="width:00.96%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFCC;padding:0pt;">   </td> <td valign="bottom" style="width:14.10%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFCC;padding:0pt;">   </td> <td valign="bottom" style="width:00.52%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFCC;padding:0pt;">   </td> </tr> <tr> <td valign="bottom" style="width:37.14%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #FFFFFF;padding:0pt 0pt 0pt 24pt;"> Employee </td> <td valign="top" style="width:00.78%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #FFFFFF;padding:0pt;">   </td> <td valign="top" style="width:00.96%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #FFFFFF;padding:0pt;"> $ </td> <td valign="top" style="width:13.42%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #FFFFFF;;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>(471 </td> <td valign="top" style="width:00.76%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #FFFFFF;"> ) </td> <td valign="top" style="width:00.78%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #FFFFFF;padding:0pt;">   </td> <td valign="top" style="width:00.96%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #FFFFFF;padding:0pt;"> $ </td> <td valign="top" style="width:11.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #FFFFFF;;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>1,574 </td> <td valign="bottom" style="width:00.94%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #FFFFFF;padding:0pt;">   </td> <td valign="bottom" style="width:00.96%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #FFFFFF;padding:0pt;"> $ </td> <td valign="bottom" style="width:14.04%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #FFFFFF;;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>(96 </td> <td valign="bottom" style="width:00.94%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #FFFFFF;"> )  </td> <td valign="bottom" style="width:00.94%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #FFFFFF;padding:0pt;">   </td> <td valign="bottom" style="width:00.96%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #FFFFFF;padding:0pt;"> $ </td> <td valign="bottom" style="width:14.10%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #FFFFFF;;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>1,681 </td> <td valign="bottom" style="width:00.52%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #FFFFFF;padding:0pt;">   </td> </tr> <tr> <td valign="bottom" style="width:37.14%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFCC;padding:0pt 0pt 0pt 24pt;"> Non-employee </td> <td valign="top" style="width:00.78%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFCC;padding:0pt;">   </td> <td valign="top" style="width:00.96%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFCC;padding:0pt;">   </td> <td valign="top" style="width:13.42%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFCC;padding:0pt;"> — </td> <td valign="top" style="width:00.76%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFCC;padding:0pt;">   </td> <td valign="top" style="width:00.78%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFCC;padding:0pt;">   </td> <td valign="top" style="width:00.96%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFCC;padding:0pt;">   </td> <td valign="top" style="width:11.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFCC;;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>5 </td> <td valign="bottom" style="width:00.94%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFCC;padding:0pt;">   </td> <td valign="bottom" style="width:00.96%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFCC;padding:0pt;">   </td> <td valign="bottom" style="width:14.04%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFCC;padding:0pt;"> — </td> <td valign="bottom" style="width:00.94%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFCC;padding:0pt;">   </td> <td valign="bottom" style="width:00.94%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFCC;padding:0pt;">   </td> <td valign="bottom" style="width:00.96%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFCC;padding:0pt;">   </td> <td valign="bottom" style="width:14.10%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFCC;;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>21 </td> <td valign="bottom" style="width:00.52%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFCC;padding:0pt;">   </td> </tr> <tr> <td valign="bottom" style="width:37.14%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #FFFFFF;padding:0pt 0pt 0pt 12pt;"> General and administrative: </td> <td valign="top" style="width:00.78%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #FFFFFF;padding:0pt;">   </td> <td valign="top" style="width:00.96%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #FFFFFF;padding:0pt;">   </td> <td valign="top" style="width:13.42%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #FFFFFF;padding:0pt;">   </td> <td valign="top" style="width:00.76%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #FFFFFF;padding:0pt;">   </td> <td valign="top" style="width:00.78%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #FFFFFF;padding:0pt;">   </td> <td valign="top" style="width:00.96%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #FFFFFF;padding:0pt;">   </td> <td valign="top" style="width:11.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #FFFFFF;padding:0pt;">   </td> <td valign="bottom" style="width:00.94%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #FFFFFF;padding:0pt;">   </td> <td valign="bottom" style="width:00.96%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #FFFFFF;padding:0pt;">   </td> <td valign="bottom" style="width:14.04%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #FFFFFF;padding:0pt;">   </td> <td valign="bottom" style="width:00.94%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #FFFFFF;padding:0pt;">   </td> <td valign="bottom" style="width:00.94%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #FFFFFF;padding:0pt;">   </td> <td valign="bottom" style="width:00.96%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #FFFFFF;padding:0pt;">   </td> <td valign="bottom" style="width:14.10%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #FFFFFF;padding:0pt;">   </td> <td valign="bottom" style="width:00.52%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #FFFFFF;padding:0pt;">   </td> </tr> <tr> <td valign="bottom" style="width:37.14%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFCC;padding:0pt 0pt 0pt 24pt;"> Employee </td> <td valign="top" style="width:00.78%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFCC;padding:0pt;">   </td> <td valign="top" style="width:00.96%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFCC;padding:0pt;">   </td> <td valign="top" style="width:13.42%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFCC;;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>1,115 </td> <td valign="top" style="width:00.76%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFCC;padding:0pt;">   </td> <td valign="top" style="width:00.78%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFCC;padding:0pt;">   </td> <td valign="top" style="width:00.96%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFCC;padding:0pt;">   </td> <td valign="top" style="width:11.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFCC;;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>699 </td> <td valign="bottom" style="width:00.94%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFCC;padding:0pt;">   </td> <td valign="bottom" style="width:00.96%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFCC;padding:0pt;">   </td> <td valign="bottom" style="width:14.04%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFCC;;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>1,511 </td> <td valign="bottom" style="width:00.94%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFCC;padding:0pt;">   </td> <td valign="bottom" style="width:00.94%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFCC;padding:0pt;">   </td> <td valign="bottom" style="width:00.96%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFCC;padding:0pt;">   </td> <td valign="bottom" style="width:14.10%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFCC;;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>809 </td> <td valign="bottom" style="width:00.52%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFCC;padding:0pt;">   </td> </tr> <tr> <td valign="bottom" style="width:37.14%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #FFFFFF;padding:0pt 0pt 1.2pt 24pt;"> Non-employee </td> <td valign="top" style="width:00.78%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #FFFFFF;padding:0pt;">   </td> <td valign="top" style="width:00.96%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #FFFFFF;padding:0pt;">   </td> <td valign="top" style="width:13.42%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #FFFFFF;padding:0pt;"> — </td> <td valign="top" style="width:00.76%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #FFFFFF;padding:0pt;">   </td> <td valign="top" style="width:00.78%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #FFFFFF;padding:0pt;">   </td> <td valign="top" style="width:00.96%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #FFFFFF;padding:0pt;">   </td> <td valign="top" style="width:11.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #FFFFFF;;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>45 </td> <td valign="bottom" style="width:00.94%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #FFFFFF;padding:0pt 0pt 1.2pt 0pt;">   </td> <td valign="bottom" style="width:00.96%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #FFFFFF;padding:0pt;">   </td> <td valign="bottom" style="width:14.04%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #FFFFFF;padding:0pt;"> — </td> <td valign="bottom" style="width:00.94%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #FFFFFF;padding:0pt 0pt 1.2pt 0pt;">   </td> <td valign="bottom" style="width:00.94%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #FFFFFF;padding:0pt 0pt 1.2pt 0pt;">   </td> <td valign="bottom" style="width:00.96%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #FFFFFF;padding:0pt;">   </td> <td valign="bottom" style="width:14.10%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #FFFFFF;;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>77 </td> <td valign="bottom" style="width:00.52%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #FFFFFF;padding:0pt 0pt 1.2pt 0pt;">   </td> </tr> <tr> <td valign="bottom" style="width:37.14%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFCC;padding:0pt 0pt 3pt 12pt;">   </td> <td valign="top" style="width:00.78%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFCC;padding:0pt;">   </td> <td valign="top" style="width:00.96%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFCC;padding:0pt;"> $ </td> <td valign="top" style="width:13.42%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFCC;;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>644 </td> <td valign="top" style="width:00.76%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFCC;padding:0pt;">   </td> <td valign="top" style="width:00.78%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFCC;padding:0pt;">   </td> <td valign="top" style="width:00.96%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFCC;padding:0pt;"> $ </td> <td valign="top" style="width:11.80%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFCC;;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>2,323 </td> <td valign="bottom" style="width:00.94%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFCC;padding:0pt 0pt 3pt 0pt;">   </td> <td valign="bottom" style="width:00.96%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFCC;padding:0pt;"> $ </td> <td valign="bottom" style="width:14.04%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFCC;;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>1,415 </td> <td valign="bottom" style="width:00.94%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFCC;padding:0pt 0pt 3pt 0pt;">   </td> <td valign="bottom" style="width:00.94%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFCC;padding:0pt 0pt 3pt 0pt;">   </td> <td valign="bottom" style="width:00.96%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFCC;padding:0pt;"> $ </td> <td valign="bottom" style="width:14.10%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFCC;;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>2,588 </td> <td valign="bottom" style="width:00.52%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCFFCC;padding:0pt 0pt 3pt 0pt;">   </td> </tr> </table></div>    </div> </div>

<div> <div style="margin-left:0pt;margin-right:0pt;"> Below is a table that presents information about certain assets and liabilities measured at fair value on a recurring basis:   <div style="width:100%"><table cellpadding="0" cellspacing="0" style="border-collapse:collapse;width: 100.76%;margin-left:0pt;"> <tr> <td valign="bottom" style="width:117.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:04.50pt;padding:0pt 0pt 1.2pt 0pt;">   </td> <td valign="bottom" style="width:09.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:76.60pt;padding:0pt;">   </td> <td valign="bottom" style="width:03.25pt;padding:0pt 0pt 1.2pt 0pt;">   </td> <td valign="bottom" style="width:03.25pt;padding:0pt 0pt 1.2pt 0pt;">   </td> <td valign="bottom" style="width:05.00pt;border-bottom:1pt solid #000000 ;padding:0pt;">   </td> <td valign="bottom" style="width:78.40pt;border-bottom:1pt solid #000000 ;padding:0pt;">   </td> <td valign="bottom" style="width:04.50pt;border-bottom:1pt solid #000000 ;padding:0pt;">   </td> <td valign="bottom" style="width:02.20pt;border-bottom:1pt solid #000000 ;padding:0pt;">   </td> <td valign="bottom" style="width:05.40pt;border-bottom:1pt solid #000000 ;padding:0pt;">   </td> <td valign="bottom" style="width:66.95pt;border-bottom:1pt solid #000000 ;padding:0pt;">   </td> <td valign="bottom" style="width:02.45pt;border-bottom:1pt solid #000000 ;padding:0pt;">   </td> <td valign="bottom" style="width:02.55pt;border-bottom:1pt solid #000000 ;padding:0pt;">   </td> <td valign="bottom" style="width:10.50pt;border-bottom:1pt solid #000000 ;padding:0pt 0pt 1.2pt 0pt;">   </td> <td valign="bottom" style="width:80.00pt;border-bottom:1pt solid #000000 ;padding:0pt;">   </td> </tr> <tr> <td valign="bottom" style="width:117.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:04.50pt;padding:0pt 0pt 1.2pt 0pt;">   </td> <td colspan="2" valign="bottom" style="width:85.60pt;padding:0pt;">   </td> <td valign="bottom" style="width:03.25pt;padding:0pt 0pt 1.2pt 0pt;">   </td> <td valign="bottom" style="width:03.25pt;padding:0pt 0pt 1.2pt 0pt;">   </td> <td colspan="8" valign="bottom" style="width:167.45pt;border-top:1pt solid #000000 ;border-bottom:1pt solid #000000 ;padding:0pt;"> Fair Value Measurements at June 30, 2014 </td> <td colspan="2" valign="bottom" style="width:90.50pt;border-top:1pt solid #000000 ;border-bottom:1pt solid #000000 ;padding:0pt 0pt 1.2pt 0pt;">   </td> </tr> <tr> <td valign="bottom" style="width:117.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:04.50pt;padding:0pt 0pt 1.2pt 0pt;">   </td> <td colspan="2" valign="bottom" style="width:85.60pt;border-bottom:1pt solid #000000 ;padding:0pt;"> June 30, 2014 </td> <td valign="bottom" style="width:03.25pt;padding:0pt 0pt 1.2pt 0pt;">   </td> <td valign="bottom" style="width:03.25pt;padding:0pt 0pt 1.2pt 0pt;">   </td> <td colspan="2" valign="bottom" style="width:83.40pt;border-bottom:1pt solid #000000 ;padding:0pt;"> Quoted Prices in Active Markets for Identical Assets (Level 1) </td> <td valign="bottom" style="width:04.50pt;padding:0pt 0pt 1.2pt 0pt;">   </td> <td valign="bottom" style="width:02.20pt;padding:0pt;">   </td> <td valign="bottom" style="width:05.40pt;padding:0pt 0pt 1.2pt 0pt;">   </td> <td valign="bottom" style="width:66.95pt;border-bottom:1pt solid #000000 ;padding:0pt;"> Significant Other Observable Inputs (Level 2) </td> <td valign="bottom" style="width:02.45pt;padding:0pt 0pt 1.2pt 0pt;">   </td> <td valign="bottom" style="width:02.55pt;padding:0pt 0pt 1.2pt 0pt;">   </td> <td colspan="2" valign="bottom" style="width:90.50pt;border-top:1pt solid #000000 ;border-bottom:1pt solid #000000 ;padding:0pt;"> Significant Unobservable Inputs (Level 3) </td> </tr> <tr> <td valign="bottom" style="width:117.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:04.50pt;padding:0pt;">   </td> <td colspan="12" valign="bottom" style="width:259.55pt;padding:0pt;"> (in thousands) </td> <td colspan="2" valign="bottom" style="width:90.50pt;padding:0pt;">   </td> </tr> <tr> <td valign="bottom" style="width:117.00pt;background-color: #CCFFCC;padding:0pt 0pt 0pt 12pt;"> Cash equivalents </td> <td valign="bottom" style="width:04.50pt;background-color: #CCFFCC;padding:0pt;">   </td> <td valign="bottom" style="width:09.00pt;background-color: #CCFFCC;padding:0pt;"> $ </td> <td valign="bottom" style="width:76.60pt;background-color: #CCFFCC;;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>118,228  </td> <td valign="bottom" style="width:03.25pt;background-color: #CCFFCC;padding:0pt;">   </td> <td valign="bottom" style="width:03.25pt;background-color: #CCFFCC;padding:0pt;">   </td> <td valign="bottom" style="width:05.00pt;background-color: #CCFFCC;padding:0pt;"> $ </td> <td valign="bottom" style="width:78.40pt;background-color: #CCFFCC;;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>118,228  </td> <td valign="bottom" style="width:04.50pt;background-color: #CCFFCC;padding:0pt;">   </td> <td valign="bottom" style="width:02.20pt;background-color: #CCFFCC;padding:0pt;">   </td> <td valign="bottom" style="width:05.40pt;background-color: #CCFFCC;padding:0pt;"> $ </td> <td valign="bottom" style="width:66.95pt;background-color: #CCFFCC;padding:0pt;"> — </td> <td valign="bottom" style="width:02.45pt;background-color: #CCFFCC;padding:0pt;">   </td> <td valign="bottom" style="width:02.55pt;background-color: #CCFFCC;padding:0pt;">   </td> <td valign="bottom" style="width:10.50pt;background-color: #CCFFCC;padding:0pt;"> $ </td> <td valign="bottom" style="width:80.00pt;background-color: #CCFFCC;padding:0pt;"> — </td> </tr> <tr> <td valign="bottom" style="width:117.00pt;background-color: #FFFFFF;padding:0pt 0pt 0pt 12pt;"> Short-term investments </td> <td valign="bottom" style="width:04.50pt;background-color: #FFFFFF;padding:0pt;">   </td> <td valign="bottom" style="width:09.00pt;background-color: #FFFFFF;padding:0pt;">   </td> <td valign="bottom" style="width:76.60pt;background-color: #FFFFFF;;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>80,996  </td> <td valign="bottom" style="width:03.25pt;background-color: #FFFFFF;padding:0pt;">   </td> <td valign="bottom" style="width:03.25pt;background-color: #FFFFFF;padding:0pt;">   </td> <td valign="bottom" style="width:05.00pt;background-color: #FFFFFF;padding:0pt;">   </td> <td valign="bottom" style="width:78.40pt;background-color: #FFFFFF;padding:0pt;"> — </td> <td valign="bottom" style="width:04.50pt;background-color: #FFFFFF;padding:0pt;">   </td> <td valign="bottom" style="width:02.20pt;background-color: #FFFFFF;padding:0pt;">   </td> <td valign="bottom" style="width:05.40pt;background-color: #FFFFFF;padding:0pt;">   </td> <td valign="bottom" style="width:66.95pt;background-color: #FFFFFF;;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>80,996  </td> <td valign="bottom" style="width:02.45pt;background-color: #FFFFFF;padding:0pt;">   </td> <td valign="bottom" style="width:02.55pt;background-color: #FFFFFF;padding:0pt;">   </td> <td valign="bottom" style="width:10.50pt;background-color: #FFFFFF;padding:0pt;">   </td> <td valign="bottom" style="width:80.00pt;background-color: #FFFFFF;padding:0pt;"> — </td> </tr> </table></div>   <div style="width:100%"><table cellpadding="0" cellspacing="0" style="border-collapse:collapse;width: 100.96%;margin-left:0pt;"> <tr> <td valign="bottom" style="width:126.10pt;padding:0pt;">   </td> <td valign="bottom" style="width:02.25pt;padding:0pt 0pt 1.2pt 0pt;">   </td> <td colspan="2" valign="bottom" style="width:06.65pt;padding:0pt;">   </td> <td valign="bottom" style="width:71.30pt;padding:0pt;">   </td> <td valign="bottom" style="width:03.50pt;padding:0pt 0pt 1.2pt 0pt;">   </td> <td colspan="2" valign="bottom" style="width:05.80pt;padding:0pt 0pt 1.2pt 0pt;">   </td> <td colspan="2" valign="bottom" style="width:13.45pt;border-bottom:1pt solid #000000 ;padding:0pt;">   </td> <td valign="bottom" style="width:71.80pt;border-bottom:1pt solid #000000 ;padding:0pt;">   </td> <td colspan="2" valign="bottom" style="width:04.55pt;border-bottom:1pt solid #000000 ;padding:0pt;">   </td> <td colspan="2" valign="bottom" style="width:04.55pt;border-bottom:1pt solid #000000 ;padding:0pt;">   </td> <td colspan="2" valign="bottom" style="width:04.50pt;border-bottom:1pt solid #000000 ;padding:0pt;">   </td> <td colspan="2" valign="bottom" style="width:58.70pt;border-bottom:1pt solid #000000 ;padding:0pt;">   </td> <td valign="bottom" style="width:04.50pt;border-bottom:1pt solid #000000 ;padding:0pt;">   </td> <td colspan="2" valign="bottom" style="width:04.50pt;border-bottom:1pt solid #000000 ;padding:0pt;">   </td> <td valign="bottom" style="width:09.20pt;border-bottom:1pt solid #000000 ;padding:0pt;">   </td> <td valign="bottom" style="width:76.60pt;border-bottom:1pt solid #000000 ;padding:0pt;">   </td> <td colspan="2" valign="bottom" style="width:04.55pt;padding:0pt 0pt 1.2pt 0pt;">   </td> </tr> <tr> <td valign="bottom" style="width:126.10pt;padding:0pt;">   </td> <td valign="bottom" style="width:02.25pt;padding:0pt 0pt 1.2pt 0pt;">   </td> <td colspan="3" valign="bottom" style="width:77.95pt;padding:0pt;">   </td> <td valign="bottom" style="width:03.50pt;padding:0pt 0pt 1.2pt 0pt;">   </td> <td colspan="2" valign="bottom" style="width:05.80pt;padding:0pt 0pt 1.2pt 0pt;">   </td> <td colspan="14" valign="bottom" style="width:166.55pt;border-bottom:1pt solid #000000 ;padding:0pt;"> Fair Value Measurements at December 31, 2013 </td> <td colspan="2" valign="bottom" style="width:85.80pt;border-bottom:1pt solid #000000 ;padding:0pt;">   </td> <td valign="bottom" style="width:03.95pt;padding:0pt 0pt 1.2pt 0pt;">   </td> </tr> <tr> <td valign="bottom" style="width:126.10pt;padding:0pt;">   </td> <td valign="bottom" style="width:02.25pt;padding:0pt 0pt 1.2pt 0pt;">   </td> <td colspan="3" valign="bottom" style="width:77.95pt;border-bottom:1pt solid #000000 ;padding:0pt;"> December 31, 2013 </td> <td valign="bottom" style="width:03.50pt;padding:0pt 0pt 1.2pt 0pt;">   </td> <td colspan="2" valign="bottom" style="width:05.80pt;padding:0pt 0pt 1.2pt 0pt;">   </td> <td colspan="6" valign="bottom" style="width:90.30pt;border-bottom:1pt solid #000000 ;padding:0pt;"> Quoted Prices in Active Markets for Identical Assets (Level 1) </td> <td colspan="2" valign="bottom" style="width:04.50pt;padding:0pt 0pt 1.2pt 0pt;">   </td> <td colspan="2" valign="bottom" style="width:04.50pt;padding:0pt 0pt 1.2pt 0pt;">   </td> <td valign="bottom" style="width:58.25pt;border-bottom:1pt solid #000000 ;padding:0pt;"> Significant Other Observable Inputs (Level 2) </td> <td colspan="2" valign="bottom" style="width:05.25pt;padding:0pt 0pt 1.2pt 0pt;">   </td> <td valign="bottom" style="width:03.75pt;padding:0pt 0pt 1.2pt 0pt;">   </td> <td colspan="2" valign="bottom" style="width:85.80pt;border-bottom:1pt solid #000000 ;padding:0pt;"> Significant Unobservable Inputs (Level 3) </td> <td valign="bottom" style="width:03.95pt;padding:0pt 0pt 1.2pt 0pt;">   </td> </tr> <tr> <td valign="bottom" style="width:126.10pt;padding:0pt;">   </td> <td valign="bottom" style="width:02.25pt;padding:0pt;">   </td> <td colspan="20" valign="bottom" style="width:253.80pt;padding:0pt;"> (in thousands) </td> <td colspan="2" valign="bottom" style="width:85.80pt;padding:0pt;">   </td> <td valign="bottom" style="width:03.95pt;padding:0pt;">   </td> </tr> <tr> <td valign="bottom" style="width:126.10pt;background-color: #CCFFCC;padding:0pt 0pt 0pt 12pt;"> Cash equivalents </td> <td valign="bottom" style="width:02.25pt;background-color: #CCFFCC;padding:0pt;">   </td> <td valign="bottom" style="width:04.85pt;background-color: #CCFFCC;padding:0pt;"> $ </td> <td colspan="2" valign="bottom" style="width:73.10pt;background-color: #CCFFCC;;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>107,349  </td> <td colspan="2" valign="bottom" style="width:04.75pt;background-color: #CCFFCC;padding:0pt;">   </td> <td valign="bottom" style="width:04.55pt;background-color: #CCFFCC;padding:0pt;">   </td> <td valign="bottom" style="width:09.95pt;background-color: #CCFFCC;padding:0pt;"> $ </td> <td colspan="3" valign="bottom" style="width:75.85pt;background-color: #CCFFCC;;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>107,349  </td> <td colspan="2" valign="bottom" style="width:04.50pt;background-color: #CCFFCC;padding:0pt;">   </td> <td colspan="2" valign="bottom" style="width:04.50pt;background-color: #CCFFCC;padding:0pt;">   </td> <td colspan="2" valign="bottom" style="width:04.50pt;background-color: #CCFFCC;padding:0pt;"> $ </td> <td valign="bottom" style="width:58.25pt;background-color: #CCFFCC;padding:0pt;"> — </td> <td colspan="2" valign="bottom" style="width:05.25pt;background-color: #CCFFCC;padding:0pt;">   </td> <td valign="bottom" style="width:03.75pt;background-color: #CCFFCC;padding:0pt;">   </td> <td valign="bottom" style="width:09.20pt;background-color: #CCFFCC;padding:0pt;"> $ </td> <td valign="bottom" style="width:76.60pt;background-color: #CCFFCC;padding:0pt;"> — </td> <td colspan="2" valign="bottom" style="width:04.55pt;background-color: #CCFFCC;padding:0pt;">   </td> </tr> </table></div>   Short-term investments consist of corporate bonds, commercial paper and certificates of deposit. </div> </div>

<div> <div style="margin-left:0pt;margin-right:0pt;"> The following warrants for the purchase of common stock were issued, outstanding and exercisable at June 30, 2014:   <div style="width:100%"><table cellpadding="0" cellspacing="0" style="border-collapse:collapse;width: 100.00%;margin-left:0pt;"> <tr> <td valign="bottom" style="width:31.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:01.16%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:17.76%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:01.16%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:01.16%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:11.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:01.16%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:01.16%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:01.16%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:11.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:01.16%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:01.16%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:17.76%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> </tr> <tr> <td valign="bottom" style="width:31.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> Class </td> <td valign="bottom" style="width:01.16%;padding:0pt;">   </td> <td valign="bottom" style="width:17.76%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> Date </td> <td valign="bottom" style="width:01.16%;padding:0pt;">   </td> <td colspan="2" valign="bottom" style="width:13.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> Shares </td> <td valign="bottom" style="width:01.16%;padding:0pt;">   </td> <td valign="bottom" style="width:01.16%;padding:0pt;">   </td> <td colspan="2" valign="bottom" style="width:13.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> Price Per Share </td> <td valign="bottom" style="width:01.16%;padding:0pt;">   </td> <td valign="bottom" style="width:01.16%;padding:0pt;">   </td> <td valign="bottom" style="width:17.76%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> Expiration </td> </tr> <tr> <td valign="bottom" style="width:31.44%;padding:0pt;"> Common </td> <td valign="bottom" style="width:01.16%;padding:0pt;">   </td> <td valign="bottom" style="width:17.76%;padding:0pt;"> February 7, 2011 </td> <td valign="bottom" style="width:01.16%;padding:0pt;">   </td> <td valign="bottom" style="width:01.16%;padding:0pt;">   </td> <td valign="bottom" style="width:11.90%;;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>1,330,958  </td> <td valign="bottom" style="width:01.16%;padding:0pt;">   </td> <td valign="bottom" style="width:01.16%;padding:0pt;">   </td> <td valign="bottom" style="width:01.16%;padding:0pt;"> $ </td> <td valign="bottom" style="width:11.90%;;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>7.26  </td> <td valign="bottom" style="width:01.16%;padding:0pt;">   </td> <td valign="bottom" style="width:01.16%;padding:0pt;">   </td> <td valign="bottom" style="width:17.76%;padding:0pt;"> February 2018 </td> </tr> </table></div>   </div> </div>

3725000

2188000

7095000

4423000

2589000

1415000

0.85

666624

704225

64788

422535

16.50

98539000

190675000

3.55

the Company's board of directors approved and implemented a 3.55-for-1 reverse split of the Company's outstanding common stock

7320000

1098000

2476995

8395000

1095000

14300000

<div> <div style="margin-left:0pt;margin-right:0pt;"> Use of Estimates The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the amounts of assets, liabilities, revenues and expenses reported in the financial statements and accompanying notes.  Actual results could differ from these estimates. </div> </div>

12360125

23067201

28446074

30111380